Penetrator assembly for accessing bone marrow

Information

  • Patent Grant
  • 11266441
  • Patent Number
    11,266,441
  • Date Filed
    Tuesday, November 26, 2019
    5 years ago
  • Date Issued
    Tuesday, March 8, 2022
    2 years ago
Abstract
A penetrator assembly for penetrating a bone and associated bone marrow is provided. The penetrator assembly may include a first connector having a first end and a second end; an outer penetrator extending from the second end of the first connector; the outer penetrator comprising a longitudinal passageway and a first tip; a second connector having a first end and a second end; and an inner penetrator extending from the second end of the second connector, the inner penetrator comprising a second tip. The first connector may be configured to engage the second connector, and the inner penetrator may be disposed in the longitudinal passageway of the outer penetrator when the first connector is engaged with the second connector.
Description

The entire contents of these above-identified applications are incorporated herein by reference in their entirety.


TECHNICAL FIELD

The present invention is related in general to a medical device to access bone marrow and more specifically to an apparatus and method for penetrating a bone and inserting a penetrator or needle into associated bone marrow.


BACKGROUND OF THE INVENTION

Every year, millions of patients are treated for life-threatening emergencies in the United States. Such emergencies include shock, trauma, cardiac arrest, drug overdoses, diabetic ketoacidosis, arrhythmias, burns, and status epilepticus just to name a few. For example, according to the American Heart Association, more than 1,500,000 patients suffer from heart attacks (myocardial infarctions) every year, with over 500,000 of them dying from its devastating complications.


An essential element for treating all such emergencies is the rapid establishment of an intravenous (IV) line in order to administer drugs and fluids directly into the circulatory system. Whether in the ambulance by paramedics, or in the emergency room by emergency specialists, the goal is the same—to start an IV in order to administer life-saving drugs and fluids. To a large degree, the ability to successfully treat such critical emergencies is dependent on the skill and luck of the operator in accomplishing vascular access. While it is relatively easy to start an IV on some patients, doctors, nurses and paramedics often experience great difficulty establishing IV access in approximately 20 percent of patients. These patients are probed repeatedly with sharp needles in an attempt to solve this problem and may require an invasive procedure to finally establish an intravenous route.


A further complicating factor in achieving IV access occurs “in the field” e.g. at the scene of an accident or during ambulance transport where it is difficult to see the target and excessive motion make accessing the venous system very difficult.


In the case of patients with chronic disease or the elderly, the availability of easily-accessible veins may be depleted. Other patients may have no available IV sites due to anatomical scarcity of peripheral veins, obesity, extreme dehydration or previous IV drug use. For these patients, finding a suitable site for administering lifesaving drugs becomes a monumental and frustrating task. While morbidity and mortality statistics are not generally available, it is known that many patients with life-threatening emergencies have died of ensuing complications because access to the vascular system with life-saving IV therapy was delayed or simply not possible. For such patients, an alternative approach is required.


Many medical devices such as syringes, hypodermic needles, catheters, IV tubing and stop cocks may include either a pin (male) or box (female) Luer type fitting. The pin end or box end may include threads which allow releasably engaging an associated medical device with other equipment having a complimentary Luer type fitting. Luer type connections may sometimes be described as Luer slips or Luer locks. Luer slips may require a half twist of an associated collar to securely engage a pin end and a box end with each other. A Luer lock functions by forming a watertight fit between a pin and a box when engaged and when twisted by a half turn or more. Luer locks frequently include a threaded locking collar on a box end which mates with ears or projections from an associated pin end to provide a more positive, locked connection. Luer connections generally form fluid tight seals. Some Luer connections may include tapered fittings.


SUMMARY OF THE INVENTION

In accordance with teachings of the present invention, an apparatus and method for communicating with or accessing bone marrow of a bone are provided. The apparatus may include a handle having a drive shaft, a connector having a first end operable to connect to the drive shaft and a second end operable to attach to a penetrator hub. The penetrator hub may include a penetrator operable to access the bone marrow.


In an alternate embodiment an apparatus for manually penetrating a bone and associated bone marrow is provided. The apparatus may include a handle having at least one drive shaft, a releasable connector with a first end operable to attach to the at least one drive shaft and a second end operable to attach to a penetrator hub. The penetrator hub having a fitting operable to attach to the connector and a penetrator operable to access the bone marrow.


In another embodiment a method of accessing bone marrow of a bone is provided. The method may include inserting a penetrator into the bone marrow using an apparatus having a handle, a drive shaft and a connector with a first end operable to connect to the drive shaft and a second end operable to connect to a penetrator assembly. For some applications, a trocar may be disposed within the penetrator assembly. After inserting portions the penetrator assembly into the bone marrow, the handle and connector may be detached from the penetrator assembly. The trocar, when used, may be removed from the penetrator assembly and associated penetrator.


In various embodiments of the apparatus the handle may be T-shaped, pistol-shaped, round or oval-shaped, an ergonomically designed grip or any other shape suitable for general or specific use. In various embodiments the handle may include a compartment for enclosing an interosseous needle, a penetrator and associated trocar or any other accessory suitable for use with the apparatus.


In another embodiment a power driven apparatus for penetrating bone marrow of a bone may be provided. The apparatus may include a housing, a motor, a gear assembly, at least one drive shaft and a power source, and at least one drive shaft operable to connect to an auxiliary device and further operable to provide rotational energy to the auxiliary device. In various embodiments the auxiliary devices may include a ring cutter, a suction machine, or a flashlight.


In certain embodiments a penetrator assembly for penetrating a bone and associated bone marrow may be provided. The penetrator assembly may include a first connector having a first end and a second end; an outer penetrator extending from the second end of the first connector; the outer penetrator comprising a longitudinal passageway and a first tip; a second connector having a first end and a second end; and an inner penetrator extending from the second end of the second connector, the inner penetrator comprising a second tip. The first connector may be configured to engage and disengage from the second connector. When the first connector is engaged with the second connector, the inner penetrator may be disposed in the longitudinal passageway of the outer penetrator, and the first tip of the outer penetrator and the second tip of the inner penetrator may form at least one continuous cutting surface.


Apparatus and methods incorporating teachings of the present invention may be used to access the bone marrow of any bone in a human or animal's body for any purpose including the delivery of fluids, medications, drugs, chemicals and any other bioactive substances including blood. Teachings of the present invention may also be used for harvesting bone marrow and/or stem cell. Teachings of the present invention may also be used to access body tissue or body cavities other than bone marrow in a human or animal species.





BRIEF DESCRIPTION OF THE DRAWINGS

A more complete and thorough understanding of the present embodiments and advantages thereof may be acquired by referring to the following description taken in conjunction with the accompanying drawings, in which like reference numbers indicate like features, and wherein:



FIG. 1A shows an example illustration of an apparatus operable for penetrating bone marrow of a bone;



FIG. 1B is a schematic drawing showing an exploded view of the apparatus in FIG. 1A;



FIG. 1C is a schematic drawing showing an end view of the apparatus in FIG. 1A;



FIG. 1D is a schematic drawing showing one example of driver and connector incorporating teachings of the present invention;



FIG. 1E is a schematic drawing showing an example of a penetrator assembly which may be releasably engaged with a handle in accordance with teachings of the present invention;



FIG. 1F is a schematic drawing in section with portions broken away showing an exploded view of a penetrator assembly having an outer penetrator and an inner penetrator which may be releasably engaged with a handle in accordance with teachings of the present invention;



FIG. 1G is a schematic drawing showing an enlarged view of a tip formed on an inner penetrator which may be in accordance with teachings of the present invention;



FIG. 1H is a schematic drawing showing an enlarged view of a tip formed on an outer penetrator in accordance with teachings of the present invention;



FIG. 1I is a schematic drawing in section and in elevation with portions broken away showing one example of an apparatus communicating with bone marrow of a bone in accordance with teachings of the present invention;



FIG. 2 shows an example illustration of an apparatus for penetrating bone marrow of a bone in accordance with teachings of the present invention;



FIG. 3A shows an example illustration of an apparatus operable for penetrating bone marrow of a bone in accordance with teachings of the present invention;



FIG. 3B shows an example illustration of an apparatus operable for penetrating bone marrow of a bone in accordance with teachings of the present invention;



FIG. 3C shows an example illustration of an apparatus operable for penetrating bone marrow of a bone in accordance with teachings of the present invention;



FIG. 3D is a schematic drawing showing an isometric view of a container operable to enclose a penetrator assembly in accordance with teachings of the present invention;



FIG. 4A shows another example illustration of an apparatus for penetrating bone marrow of a bone in accordance with teachings of the present invention;



FIG. 4B is a schematic drawing in section with portions broken away showing one example of a penetrator assembly which may be releasably engaged with a drive shaft in accordance with teachings of the present invention;



FIG. 4C is a schematic drawing in section with portions broken away showing another example of an opening formed in a penetrator assembly which may be releasably engaged with a drive shaft in accordance with teachings of the present invention;



FIG. 4D is a schematic drawing in section with portions broken away showing still another example of an opening formed in a penetrator assembly which may be releasably engaged with a drive shaft in accordance with teachings of the present invention;



FIG. 5A shows an example illustration of an auxiliary device which may be modified for use with apparatus operable for penetrating bone marrow of a bone in accordance with teachings of the present invention;



FIG. 5B shows an example illustration of a power driven apparatus operable for penetrating bone marrow of a bone and compatible with operating an auxiliary device; and



FIG. 6A is a schematic drawing showing an exploded view of another example of apparatus operable for penetrating bone marrow of a bone in accordance with the teachings of the present invention;



FIG. 6B is a schematic drawing showing still another example of an apparatus operable for penetrating bone marrow of a bone in accordance with teachings of the present invention; and



FIG. 7 is a schematic, exploded drawing showing one example of fitting satisfactory for attachment of tubing with a hub and penetrator in accordance with teachings of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Some preferred embodiments of the invention and its advantages are best understood by reference to FIGS. 1A-7 wherein like numbers refer to same and like parts.


Various aspects of the present invention may be described with respect to treating human patients. However, apparatus and methods incorporating teachings of the present invention may be used to treat veterinary patients as well.


There are times when availability or advisability of having a battery powered driver for interosseous (IO) access is not possible. Such conditions may involve military special operations where extreme temperatures and severe weight restrictions limit what can be carried into battle. The same may be true for civilian emergency medical services (EMS) or first responders where long shelf life and infrequent use make the convenience of a battery powered driver impractical. For this reason, a manual driver offers certain advantages over a battery powered driver. Establishing interosseous access with a manual driver may sometimes take longer than with a powered driver. However, a bone may be penetrated and associated bone marrow accessed using either driver. When a manual driver is used, manual force may be exerted on a handle or grip to insert a penetrator or needle into the bone to access the bone marrow. A manual driver may also serve as a useful backup in cases where a battery powered driver fails to function, for example, due to a depleted power supply.



FIGS. 1A, 1B and 1C show one embodiment of manual driver 10a wherein handle 12a includes drive shaft 16a. Manual driver 10a may also include an optional ratchet mechanism such as shown in FIG. 3A. Handle 12a may be formed in a variety of shapes, such as with fingergrips 20. Handle 12a may be formed from materials satisfactory for multiple uses or may be formed from materials satisfactory for one time or disposable use. T-shaped handle 12e (See FIG. 3C), substantially round or oval shaped handle 12a (See FIGS. 1A and 1B), pistol-grip handle 12b (See FIG. 2) or any other ergonomically designed shape suitable for grasping with the hand or fingers during manual insertion of a penetrator may be used.


Various techniques may be satisfactorily used to releasably engage or attach a handle with an associated connector and/or penetrator in accordance with teachings of the present invention. For some applications a handle and an associated connector may be formed as a single unit. See FIGS. 6A and 6B. In such a configuration the handle/connector combination is operable to attach to a hub of a tissue penetrator. The handle and connector may or may not be detachable from each other. For other applications, a handle may be releasably engaged to a hub and associated penetrator without the use of a connector.



FIG. 1B shows apparatus 10a with the components separated. Handle 12a includes optional finger grips or finger rests 20. Drive shaft or attachment 16a may be releasably engaged with end 181 of connector 180. Inner penetrator or trocar 220 extends from end 182 of connector 180. Connector 180 and attached inner penetrator 220 may be releasably engaged with each other by Luer type fittings, threaded connections or other suitable fittings formed on first end 201 of hub 200. Outer penetrator 210 extends from second end 202 of hub 200.



FIG. 1C shows an end on view of apparatus 10a.



FIG. 1D opening 186 may be formed in first end 181 to receive associated drive shaft 16a. See FIG. 1D. Opening 186 may be formed with various configurations and/or dimensions. For some applications opening 186 may include a passageway or channel sized to receive portions of drive shaft 16a. One or more webs 136 may be formed in end 181 extending from opening 186. Open segments or void spaces 138 may be formed between webs 136. Respective projections 146 extending from adjacent portions of handle 12a may be releasably engaged with webs 136 and void spaces 138. Opening 186 and associated web 136 may be used to releasably couple connector 180 with either a manual driver or a powered driver. An example of a powered driver is shown in FIG. 5B.



FIG. 1E shows an enlarged view of penetrator assembly 160.


As shown in FIG. 1F, penetrator assembly 160 may include connector 180, hub and associated hub 200, outer penetrator 210 and inner penetrator 220. Penetrator assembly 160 may include an outer penetrator such as a cannula, hollow tube or hollow drill bit and an inner penetrator such as a stylet or trocar. Various types of stylets and/or trocars may be disposed within an outer penetrator. For some applications outer penetrator or cannula 210 may be described as a generally elongated tube sized to receive inner penetrator or stylet 220 therein. Portions of inner penetrator 220 may be disposed within longitudinal passageway 184 extending through outer penetrator 210. The outside diameter of inner penetrator 220 and the inside diameter of longitudinal passageway 184 may be selected such that inner penetrator 220 may be slidably disposed within outer penetrator 210.


Metal disc 70 may be disposed within opening 186 for use in releasably attaching connector 180 with a magnetic drive shaft. For some applications, drive shaft 16a may be magnetized. End 223 of inner penetrator 220 is preferably spaced from metal disc 70 with insulating or electrically nonconductive material disposed therebetween.


Tip 211 of outer penetrator 210 and/or tip 222 of inner penetrator 220 may be operable to penetrate bone and associated bone marrow. The configuration of tips 211 and/or 222 may be selected to penetrate a bone or other body cavities with minimal trauma. First end or tip 222 of inner penetrator 220 may be trapezoid shaped and may include one or more cutting surfaces. In one embodiment outer penetrator 210 and inner penetrator 220 may be ground together as one unit during an associated manufacturing process. Providing a matching fit allows respective tips 211 and 222 to act as a single drilling unit which facilitates insertion and minimizes damage as portions of penetrator assembly 160 are inserted into a bone and associated bone marrow. Inner penetrator 220 may also include a longitudinal groove (not expressly shown) that runs along the side of inner penetrator 220 to allow bone chips and/or tissues to exit an insertion site as penetrator assembly 160 is drilled deeper into an associated bone. Outer penetrator 210 may be formed from stainless steel, titanium or other materials of suitable strength and durability to penetrate bone.


Hub 200 may be used to stabilize penetrator assembly 160 during insertion of an associated penetrator into a patient's skin, soft tissue and adjacent bone at a selected insertion site. First end 201 of hub 200 may be operable for releasable engagement or attachment with associated connector 180. Second end 202 of hub 200 may have a size and configuration compatible with an associated insertion site for outer penetrator 210. The combination of hub 200 with outer penetrator 210 may sometimes be referred to as a “penetrator set” or intraosseous needle.


For some applications connector 180 may be described as a generally cylindrical tube defined in part by first end 181 and second end 182. The exterior of connector 180 may include an enlarged tapered portion adjacent to end 181. A plurality of longitudinal ridges 190 may be formed on the exterior of connector 180 to allow an operator to grasp associated penetrator assembly 160 during attachment with a drive shaft. See FIG. 1E. Longitudinal ridges 190 also allow connector 180 to be grasped for disengagement from hub 200 when outer penetrator 210 has been inserted into a bone and associated bone marrow.


Second end 182 of connector 180 may include opening 185 sized to receive first end 201 of hub 200 therein. Threads 188 may be formed in opening 185 adjacent to second end 182 of connector 180. Threaded fitting 188 may be used in releasably attaching connector 180 with threaded fitting 208 adjacent to first end 201 of hub 200.


First end 201 of hub 200 may include a threaded connector 208 or other suitable fittings formed on the exterior thereof. First end 201 may have a generally cylindrical pin type configuration compatible with releasably engaging second end or box end 182 of connector 180.


For some applications end 202 of hub 200 may have the general configuration of flange. Angular slot or groove 204 sized to receive one end of protective cover or needle cap 234 may be formed in end 202. Slot or groove 204 may be used to releasable engage cover 234 with penetrator assembly 160. See FIGS. 1A, 1E and 2. For some applications cover 234 may be described as a generally hollow tube having rounded end 232. Cover 234 may be disposed within associated slot 204 to protect portions of outer penetrator 210 and inner penetrator 220 prior to attachment with an associated handle. Cover 234 may include a plurality of longitudinal ridges 236 formed on the exterior thereof. Longitudinal ridges 236 cooperate with each other to allow installing and removing cover or needle cap 234 without contaminating portions of an associated penetrator. Cover 234 may be formed from various plastics and/or metals.


The dimensions and configuration of second end 202 of hub 200 may be varied to accommodate various insertion sites and/or patients. Hub 200 may be satisfactorily used with a wide variety of flanges or other configurations compatible for contacting a patient's skin. Also, end 202 and associated flange may be used with a wide variety of hubs. The present invention is not limited to hub 200, end 202 or the associated flange. Passageway 206 may extend from first end 201 through second end 202. The inside diameter of passageway 206 may be selected to securely engage the outside diameter of penetrator 210. The dimensions and configuration of passageway 206 may be selected to maintain an associated penetrator assembly engaged with hub 200.



FIG. 1G shows an enlarged view of tip 222 formed on the end of inner penetrator 220 disposed within outer penetrator 210. FIG. 1H shows an enlarged view of tip 211 formed on the end of outer penetrator 210.


In one embodiment of the invention steps for penetrating into bone marrow may include turning or rotating a drive shaft to insert penetrator 24 (See FIG. 4A), penetrator 110 (See FIG. 4B) or penetrator 210 (See FIG. 1A-1B) into a bone and associated bone marrow using rotational motion, disengaging an associated drive shaft from connector 80 or 180 and disengaging connector 80 or 180 from associated hub 100 or 200 leaving hub 100 or 200 and attached penetrator 24, penetrator 110 or penetrator 210 disposed in the bone marrow. The depth of penetration into a bone and associated bone marrow may be determined by the distance between second end 102 of hub 100 and the extreme end of tip 30 or tip 111 or the distance between second end 202 of hub 200 and the extreme end of tip 211. For some applications, threaded connection or fittings 108 or 208 may allow attachment with various types of Luer locks and/or Luer fittings associated with of intravenous tubing or a syringe with first end 101 of hub 100 or first end 201 of hub 200.



FIG. 1I shows outer penetrator or cannula 110 inserted into bone 130 and associated bone marrow 140. Various types of connections may be used to communicate fluids to bone marrow 140 via outer penetrator 210 may then be used to connect intravenous tubing 150 to outer penetrator 210. Right angle connector 132 has the advantage of allowing tubing 150 to be connected to outer penetrator 110 at an angle that will not kink or pinch off the lumen of tubing 150. Lock nut 133 may be used to engage right angle connector 132 with hub 200.



FIG. 1I illustrates only one example of a connector that may be used to communicate fluids between outer penetrator 110 and tubing 150. Intravenous tubing may be used to provide intravenous fluids and/or medications to associated bone marrow. The tubing may also be used in withdrawing a sample of blood from the bone marrow. Other connectors or adapters may also be used to connect a penetrator to an intravenous tubing, other types of tubing and/or a syringe. See FIG. 7.


Apparatus formed in accordance with teachings of the present invention may have ergonomic designs that allow insertion pressure or forces, for example, manual force, to be applied with relative ease and at the same time permit rotation action of an associated handle. In FIG. 3C drive shaft 16 with associated handle 12e may be aligned with an anatomically neutral position of an operator's hand and wrist as it pronates and suppinates. This alignment may allow better axial orientation of a penetrator assembly as an associated penetrator is inserted into a bone and associated bone marrow with less chance of excessive movement and/or misalignment of the penetrator which might result in undesired widening and/or elongation of an associated insertion hole. Insertion forces are not limited to rotation but may include reciprocal or direct axial forces applied by manual force.



FIG. 2 shows another example of apparatus which may be used to insert a penetrator into bone marrow in accordance with teachings of the present invention. FIG. 2 shows manual driver 10b wherein handle 12b includes drive shaft 16b. Manual driver 10b may also include an optional ratchet mechanism such as shown in FIG. 3A. Handle 12b may be releasably engaged with penetrator assembly 160 and for any other penetrator assembly incorporating teachings of the present invention.


Apparatus 10c as shown in FIG. 3A may also include first drive shaft 16a and second drive shaft 16c. Drive shafts 16a and 16c may include respective ratchet mechanisms 14. Drive shaft 16a and 16c may be disposed at different angles with respect to handle 12c to accommodate different insertion sites for an associated penetrator assembly and/or to accommodate different types of penetrator assemblies. Drive shafts 16a and 16c may have the same round shaped cross section or may have different cross sections.


For embodiments of the present invention such as shown in FIG. 3A, apparatus 10c may include handle 12c having at least one chamber 40 disposed therein. The configuration and size of chamber 40 (as shown in dotted lines in FIG. 3A) may be selected to accommodate one or more penetrator assemblies and/or other devices. Cap 42 may be secured on one end of handle 12c to retain a penetrator assembly or other device within chamber 40.


As discussed later in more detail, penetrator assemblies are preferably disposed within a sealed container prior to use. An example of one container incorporating teachings of the present invention is shown in FIG. 3D. Penetrator assembly 160 is shown in dotted lines in chamber 40 to indicate that various items other than container 43 may be satisfactorily disposed within a handle in accordance with teachings of the present invention. Chamber 40 may be configured to accommodate one or more containers 43 and/or multiple devices.


Apparatus 10d as shown in FIG. 3B may include handle 12d having a modified configuration as compared to previously described handles. Drive shaft 16b may have four sides which define a generally square or rectangular cross section. Drive shaft 16b may also have five (5) sides, six (6) sides or a key shape. Handle 12d also includes chamber 40 with container 43 disposed therein. As previously noted, apparatus 10e as shown in FIG. 3C may include generally T-shaped handle 12e.


As shown in FIG. 3D, container 43 includes an attached lid 44. Lid 44 includes tab 46 configured to be flipped open with one or more digits of the hand. Lid 44 of container 43 may be opened with one hand of an operator. With lid 44 open, an operator may engage a penetrator assembly with a drive shaft of either a manual or powered driver held in the other hand of the operator. Flexible strap 48 may be used to releasably engage lid 44 with container 43. A container incorporating teachings of the present invention allows a penetrator assembly to be retained in a sterile environment. When use of the penetrator assembly is required, a manual or powered driver may be engaged with a penetrator assembly incorporating teachings of the present invention without contaminating the penetrator assembly. As discussed later in more detail various mechanisms such as magnets, o-rings and/or ball detents may be satisfactorily used to allow releasable engagement of a drive shaft with a penetrator assembly.


Ratchet mechanism 14 (See FIGS. 3A, 3B and 3C) is an optional component that may be included in some embodiments to provide additional leverage for insertion of an associated penetrator. For example, a ratchet may function by engaging a connector attached to a hub of a needle assembly when rotational power is applied in a clockwise direction. Ratchet mechanism 14 may be reversible such that an associated handle may be rotated in either a clockwise or counterclockwise direction. Apparatus incorporating teachings of the present invention may include a rotatable collar (not expressly shown) configured to lock and unlock a reversible ratchet mechanism in order to change the direction of rotation. Drive shafts incorporating teachings of the present invention may be connected to ratchet mechanism 14 to apply rotational force in only one direction. Ratchet mechanism 14 may be a “silent” type, including three ball bearings (not expressly shown) configured to produce a desired effect without accompanying noise produced by a conventional ratchet. Drive shafts may also be attached to handle incorporating teachings of the present invention (not expressly shown) without the use of ratchet mechanism 14.


Various types of penetrators and penetrator assemblies may be satisfactorily used with a handle incorporating teachings of the present invention. Examples of such penetrators and penetrator assemblies include, but are not limited to, penetrator assembly 22 as shown in FIG. 1A, penetrator assembly 22 as shown in FIG. 4A and penetrator assembly 60 as shown in FIG. 4B. For some applications penetrator assembly 22 may include connector 80, hub 100 and penetrator 24 as shown in FIG. 4A. For some applications penetrator assembly 60 may include connector 80, hub 100, cannula 110 and trocar 120 as shown in FIG. 4B. For some applications penetrator assembly 160 may include connector 180, hub 200, cannula 210 and trocar or stylet 220 as shown in FIG. 1A. Apparatus and methods incorporating teachings of the present invention may be used with a wide variety of handles, connectors, hubs and penetrators. The present invention is not limited to handles, connectors, flanges, penetrators and/or penetrator assemblies as shown in FIGS. 1A-6B. For some applications a handle or driver may be directly attached to a penetrator hub without the use of a connector.


For some applications a penetrator assembly may include only a single, hollow penetrator. For other applications a penetrator assembly may include an outer penetrator such as a cannula, hollow needle or hollow drill bit and an inner penetrator such as a stylet, trocar or other removable device disposed within the outer penetrator. Penetrator 24 is one example of a single, hollow penetrator. See FIG. 4A. Penetrator 24 may include one or more sideports (not expressly shown.) Cannulas 110 and 210 are examples of outer penetrators. Trocar 120 and stylet 220 are examples of an inner penetrator. See FIGS. 1B and 1E.


The size of a penetrator may vary depending upon the intended application for the associated penetrator assembly. Penetrators may be relatively small for pediatric patients, medium size for adults and large for oversize adults. By way of example, a penetrator may range in length from five (5) mm to thirty (30) mm. The diameter of a penetrator may range from eighteen (18) gauge to ten (10) gauge. The length and diameter of the penetrator used in a particular application may depend on the size of a bone to which the apparatus may be applied. Penetrators may be provided in a wide variety of configurations depending upon intended clinical purposes for insertion of the associated penetrator. For example, there may be one configuration for administering drugs and/or fluids to a patient's bone marrow and an alternative configuration for sampling bone marrow and/or blood from a patient. Other configurations may be appropriate for bone and/or tissue biopsy. Some penetrators may be suitable for more than one purpose. The configuration and size of a penetrator may also vary depending upon the site chosen for insertion of each penetrator.


As shown in FIG. 4A, penetrator assembly 22 may include connector 80, hub and associated flange 100 and penetrator 24. For some applications penetrator 24 may be generally described as a hollow needle satisfactory for communicating fluids with bone marrow. Penetrator 24 may be configured to penetrate bone, bone marrow, or other tissues or cavities of a body. Various types of intraosseous needles and/or hollow drill bits may be used as penetrator 24. Tip 30 of penetrator 24 may be satisfactory for use in drilling a hole in a bone in response to rotation of handle 22. An opening (not expressly shown) may be formed in penetrator 24 approximate tip 30 to allow communication of fluids between a fluid flow passage (not expressly shown) formed in penetrator 24 and adjacent bone marrow.


As shown in FIGS. 4A and 4B, hub 100 may be used to stabilize a penetrator assembly during insertion of an associated penetrator through a patient's skin, soft tissue and adjacent bone at a selected insertion site. First end 101 of hub 100 may be operable for releasable engagement or attachment with associated connector 80. Second end 102 and associated flange of hub 100 may have a size and configuration compatible with an associated insertion site for penetrator 24. The combination of hub 100 with penetrator 24 may sometimes be referred to as “a penetrator set or assembly.”


Various techniques may be satisfactorily used to releasably engage connector 80 with hub 100 and penetrator 24. For example, various types of mechanical fasteners including, but not limited to, mechanical fittings and threaded connections and/or Luer lock nuts may be satisfactorily used to releasably engage a handle with a penetrator in accordance with teachings of the present invention.


For some applications, connector 80 may be described as a generally cylindrical rod defined in part by first end 81 and second end 82. Longitudinal passageway 84 may extend from first end 81 through a portion of connector 80. For embodiments such as shown in FIG. 4B passage 84 preferably terminates prior to disc 70. For some applications longitudinal passageway 84 may be sized to receive a stylet or trocar. See FIG. 4B. For other applications connector 80 may be satisfactorily used without longitudinal passageway 84.


An enlarged opening may be formed in first end 81 to receive drive shaft 16. Threaded fitting 88 may be formed adjacent to second end 82 of connector 80 for use in releasably attaching connector 80 with first end 101 of hub 100. For some applications a plurality of ridges or indentations 90 may be formed on the exterior of connector 80 to allow an operator to grasp penetrator assembly 22 during attachment with drive shaft 16. Ridges or indentations 90 also allow connector 80 to be grasped for disengagement from hub 100 when penetrator 24 has been inserted into a bone and associated bone marrow.


For some applications end 102 of hub 100 may include an annular slot or groove 104 sized to receive one end of protective cover 32. Slot or groove 104 may be used to releasably engage cover 32 with penetrator assembly 22 and/or penetrator assembly 60. See FIG. 4B. For some applications cover 32 may be described as a generally hollow tube having rounded end 34. Cover 32 may be disposed within associated slot 104 to protect portions of a penetrator prior to attachment with a manual or power driver. Cover 32 may be formed from various plastics and/or metals and may be employed with alternate penetrator assembly embodiments.


The dimensions and configuration of second end 102 of hub 100 may be varied to accommodate various insertion sites and/or patients. Passageway 106 may extend from first end 101 through hub 100 to second end 102. The inside diameter of passageway 106 may be selected to securely engage the outside diameter of penetrator 24 and/or the outside diameter of cannula 110. The dimensions and configuration of passageway 106 may be selected to maintain an associated penetrator securely engaged with hub 100. Several techniques and methods may be used to secure a penetrator with a hub including, but not limited to, knurling, shot peening, flanges (not expressly shown) glue and/or serrations.


First end 101 of hub 100 may include threaded connection 108 or other suitable fitting on the exterior thereof. First end 101 may have a generally cylindrical pin type configuration compatible with releasably engaging second end or box end 82 of connector 80. Threaded connection 88 may be releasably engaged with threads 108.


Connectors 80, 80b, 80c and 80d may have similar exterior configurations and dimensions as respectively shown in FIGS. 4A, 4B, 4C and 4D. However, the dimensions and configurations of connectors incorporating teachings of the present invention may be substantially modified as compared to connectors 80, 80b, 80c and 80d.


Opening 86 in each connector 80 may have various configurations and dimensions for releasable engagement with an associated drive shaft. For some applications a drive shaft may have four sides, five sides, six sides, or eight sides. A drive shaft may also have a “D shaped” cross section. The drive shaft may also be round or any other keyed configuration. Drive shafts and associated openings in a connector may be tapered relative to each other (not expressly shown).


Drive shaft 16 as shown in FIG. 4A may have five sides. Corresponding opening 86b as shown in FIG. 4B may also include five sides compatible with releasably receiving drive shaft 16. For some applications, metallic disc 70 may be disposed within opening 86b opposite from end 81. Metallic disc 70 may be satisfactorily used to releasably engage penetrator assembly 60 as shown in FIG. 4B with a drive shaft formed from materials which are magnetized. Drive shaft 16 may include or incorporate a magnet configured to releasably engage metallic disc 70 disposed within penetrator assembly 60. Cooperation between metallic disc 70 and magnetized drive shaft 16 allows removing a penetrator assembly from a container such as container 43.


For other applications one or more magnets 72 and 74 may be disposed within the sides of opening 86 to releasably engage an associated drive shaft with connector 80b. Magnets 72 and 74 are shown in dotted lines in FIG. 1B. Magnets 72 and/or 74 may be used to releasably engage a connector with a drive shaft formed from appropriate metal alloys or other materials.


For embodiments of the present invention such as shown in FIG. 4C, opening 86c may have a generally circular shaped cross section. O-ring 96 may be disposed within opening 86c of connector 80c. O-ring 96 may form a satisfactory engagement with an associated drive shaft having a corresponding generally circular cross section. Drive shafts 16a and 16c as shown in FIG. 3A may have a generally circular cross section.


Connector 80d as shown in FIG. 4D may include ball 96 and spring 98 which engage a corresponding detent or recess (not expressly shown) in a drive shaft. Ball detent mechanism 96 and spring 98 may cooperate with each other to releasably engage connector 80d and associated penetrator assembly with a drive shaft. Other mechanisms may also be satisfactorily used to releasably engage a drive shaft with a connector in accordance with teachings of the present invention. Such mechanisms include but are not limited to snap ring connectors (not expressly shown), lock and key connectors (not expressly shown), and similar releasable connections.


For embodiments such as shown in FIG. 4B, various types of threaded connections or other suitable fittings may be used. End 82 of connector 80 preferably includes an enlarged opening or passageway sized to receive first end 101 of hub 100. Threads 88 formed within end 82 may be releasably engaged with threads 108 formed on the exterior of end 101.


For embodiments of the present invention such as shown in FIG. 4B, penetrator assembly 60 may include an outer penetrator such as a cannula, hollow needle or hollow drill bit and an inner penetrator such as a stylet or trocar. Various types of stylets and/or trocars may be disposed within an outer penetrator. For some applications, outer penetrator or cannula 110 may be described as having a generally elongated, hollow tube sized to receive inner penetrator or trocar 120 therein. Portions of trocar 120 may be disposed within longitudinal passageway 84 extending through connector 80. The outside diameter of trocar 120 and the inside diameter of longitudinal passageway 84 may be selected such that trocar 120 may be securely engaged with connector 80. For some applications, metallic disk 70 may be disposed within opening 86 adjacent to trocar 120.


Tip 111 of outer penetrator 110 and/or tip 112 of inner penetrator 120 may be operable to penetrate bone and associated bone marrow. The configuration of tips 111 and/or 121 may be selected to penetrate a bone or other body cavities with minimal trauma. First end or tip 121 of trocar 120 may include one or more cutting surfaces. In one embodiment outer penetrator 110 and inner penetrator 120 may be ground separately during the manufacturing process and later aligned to ensure an exact fit to allow respective tips 111 and 121 act as a single drilling unit to facilitate insertion and minimize damage as portions of penetrator assembly 60 are inserted into a bone and associated marrow. The resulting configuration of tips 111 and 121 may be formed to penetrate a bone or other body cavities with minimal trauma.


Inner penetrator 120 may also include a longitudinal groove (not expressly shown) that runs along the side of inner penetrator 120 to allow bone chips and/or tissue to exit an insertion site as penetrator assembly 60 is drilled deeper into an associated bone. Cannula 110 may be formed from stainless steel, titanium or other materials of suitable strength and durability to penetrate bone.


A wide variety of accessory tools and devices are frequently carried by emergency medical service personnel and/or first responders. Ring cutter 50 as shown in FIG. 5A may be representative of such accessory tools. Ring cutter 50 may include thumb lever 52 and finger protector 54. Ring cutting blade 56 may be rotatably mounted on arm 58 extending from handle 12f.


For some applications, ring cutting blade 56 may be engaged with a hub incorporating teachings of the present invention. For example, ring cutting blade 56 may be securely engaged with hub 100b such as shown in FIG. 5B. First end 101 of hub 110b may be modified to have opening 86b similar to opening 86b as described with respect to connector 80b. For some applications, handles 12, 12a, 12b, 12c, 12d and/or 12e may be releasably engaged with hub or hub 100b for use in rotating ring cutting blade 56. For other applications, power driven driver 312 may be attached with hub or hub 100b. Driver 312 may include electrical motor 314 coupled with drive shaft 300. Batteries or power supply 318 may be disposed within powered driver 312. Trigger 320 may be used to activate motor 314.


Examples of power drivers which may be used with a hub or flange are shown in U.S. Pat. No. 6,183,442 entitled “Tissue Penetrating Device and Methods of Using Same” and U.S. Pat. No. 5,554,154 entitled “Intra-Osseous Needle Drill.” Power drivers are also shown in pending U.S. patent application Ser. No. 10/449,503 entitled “Apparatus and Method to Provide Emergency Access to Bone Marrow” filed May 30, 2003 and Ser. No. 10/449,476 entitled “Apparatus and Method to Access Bone Marrow” filed May 30, 2003.


Having a reliable powered driver may be of benefit to an operator in other situations requiring rotational forces or power. For example, drive shaft 300 may be mated to a variety of auxiliary devices that may be powered by rotational or reciprocal motion. Other examples of accessory or auxiliary devices (not expressly shown) which may be attached with a handle in accordance with teachings of the present invention include, but are not limited to, orthopedic fixation devices, portable suction devices, flashlights or any other medical or field device that uses a power source. Flashlight attachments to either a manual or powered driver may include a red light for night vision purposes or a white light (not expressly shown). Such lights may be of the LED type.



FIGS. 1A, 2, 3A-3C, 6A and 6B and 1B show embodiments of the present invention which include a manual driver which may be releasably engaged with a hub in accordance with the teachings of the present invention. Apparatus 10f as shown in FIG. 6A may include handle 12f with connector 280 formed as an integral component thereof. Various types of threaded connections and/or other fittings may be satisfactorily used to releasably engage driver 10f with hub 200. For some applications, threaded connection 188 may be formed within connector 280 for releasable engagement with threaded connection 208 formed on hub 200. In FIG. 6A, apparatus 10f may include penetrator or trocar 220 extending from handle 12f.



FIG. 6B shows apparatus 10g which includes handle 12g and hub 200. For embodiments of the present invention such as shown in FIG. 6B, apparatus 10g does not include a penetrator or trocar. Hub 200 may include previously described penetrator 24 with sideport or opening 26 formed therein.



FIG. 7 is a schematic drawing showing one example of a Luer type fitting or Luer type connection which may be satisfactorily formed between hub 200 and an intravenous tubing 150. Male fitting 40 may be inserted into one end of tubing 150. Male fitting 40 preferably includes tapered surface 62 designed to form a fluid tight seal with tapered surface 64 formed with hub 200 adjacent to end 210. Tapered surfaces 62 and 64 cooperate with each to form portions of a fluid tight Luer fitting or connection. Luer locking nut or luer collar 133 may be used to securely engage tapered surface 62 and 64 with each other. Luer locking nut 133 may be securely engaged with threads 208 formed on the exterior of hub 200 adjacent to end 201. After hub 200 and associated penetrator 210 have been disposed at a selected insertion site, male type Luer fitting 36 may be slideably disposed in female type Luer fitting 38. Luer fittings 36 and 38 preferably have tapered surfaces which engage with each other to form a substantially fluid tight seal between each other. Luer lock 133 may be used to securely engage to retain secure engagement between Luer fittings 36 and 38.


Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alternations can be made herein without departing from the spirit and scope of the invention as defined by the following claims.

Claims
  • 1. A penetrator assembly for penetrating a bone and associated bone marrow, the penetrator assembly comprising: a hub having a first end and a second end, the first end of the hub including a threaded fitting configured to engage a complementary luer connector;a connector having a first end and a second end, the first end of the connector configured to releasably couple the connector with a driver, and the second end of the connector configured to releasably engage the first end of the hub;a stylet extending from the connector, the stylet including a stylet tip operable to penetrate the bone and associated bone marrow;a cannula extending from the hub, the cannula including a cannula tip operable to penetrate the bone and associated bone marrow; anda longitudinal passageway within the cannula, the longitudinal passageway sized to slidably receive a portion of the stylet when the connector is engaged with the hub,wherein the first end of the connector comprises an opening configured to receive a portion of a drive shaft of the driver, and a metal disc disposed within the opening of the first end of the connector, the metal disc configured to releasably engage a magnetic portion of the drive shaft of the driver, andwherein the first end of the hub comprises a recess having a first tapered surface, the recess configured to receive a male portion of the luer connector having a second tapered surface, wherein the first tapered surface and the second tapered surface form a fluid tight seal when the recess receives the male portion of the luer connector.
  • 2. The penetrator assembly of claim 1, further comprising a handle configured to manually drive the connector.
  • 3. The penetrator assembly of claim 2, wherein the handle has an ergonomic grip shape suitable for grasping during manual insertion of the stylet and cannula into the bone and associated bone marrow.
  • 4. The penetrator assembly of claim 3, wherein the handle is configured to allow manual insertion forces to be applied and at the same time permit rotation of the handle.
  • 5. The penetrator assembly of claim 4, wherein the handle is releasably attached to the connector.
  • 6. The penetrator assembly of claim 1, wherein the driver is a manual driver.
  • 7. The penetrator assembly of claim 1, wherein the driver is a powered driver.
  • 8. The penetrator assembly of claim 1, wherein the stylet tip and the cannula tip form a cutting surface when the connector is engaged with the hub, the cutting surface configured to penetrate the bone and associated bone marrow.
  • 9. The penetrator assembly of claim 1, wherein the second end of the hub comprises an annular groove.
  • 10. The penetrator assembly of claim 9, further comprising a protective cover configured to engage the annular groove of the second end of the hub such that the protective cover encloses the cannula tip.
  • 11. The penetrator assembly of claim 1, further comprising a plurality of longitudinal ridges formed on an exterior of the connector to facilitate disengagement of the connector from the hub when the cannula has been inserted into the bone and associated bone marrow.
  • 12. The penetrator assembly of claim 1, wherein the second end of the hub comprises a flange configured to contact skin proximate to a penetration site of the penetrator assembly.
  • 13. A penetrator assembly for penetrating a bone and associated bone marrow, the penetrator assembly comprising: a hub having a first end and a second end, the first end of the hub configured to engage a complementary luer connector, wherein the first end of the hub includes a threaded fitting and a recess, the threaded fitting configured to releasably engage a threaded portion of the luer connector, and the recess configured to receive a male portion of the luer connector, wherein a fluid tight seal is formed when the recess receives the male portion of the luer connector;a cannula extending from the second end of the hub, the cannula including a cannula tip operable to penetrate the bone and associated bone marrow;a connector having a first end and a second end, the first end of the connector configured to releasably couple the connector with a driver, and the second end of the connector configured to releasably engage the first end of the hub, wherein the first end of the connector comprises an opening configured to receive a portion of a drive shaft of the driver, and a magnet disposed within the opening of the first end of the connector to releasably engage a portion of the drive shaft of the driver;a stylet extending from the second end of the connector, the stylet including a stylet tip operable to penetrate the bone and associated bone marrow;a longitudinal passageway within the cannula, the longitudinal passageway sized to slidably receive a portion of the stylet when the connector is engaged with the hub.
  • 14. The penetrator assembly of claim 13, further comprising a handle releasably attached to the connector and configured to manually drive the connector.
  • 15. The penetrator assembly of claim 1, wherein the stylet tip and the cannula tip form a cutting surface when the connector is engaged with the hub, the cutting surface configured to penetrate the bone and associated bone marrow.
RELATED APPLICATIONS

This application is a continuation application of U.S. patent application Ser. No. 15/255,938, now U.S. Pat. No. 10,492,830, entitled “Penetrator Assembly for Accessing Bone Marrow,” filed Sep. 2, 2016, which is a continuation application of U.S. patent application Ser. No. 12/787,228, now U.S. Pat. No. 9,433,400, entitled “Manual Intraosseous Device,” filed May 25, 2010, which is a divisional application of U.S. patent application Ser. No. 11/042,912, now U.S. Pat. No. 8,641,715, entitled “Manual Intraosseous Device,” filed Jan. 25, 2005, which is a continuation-in-part application of U.S. patent application Ser. No. 10/449,476, now U.S. Pat. No. 7,699,850, entitled “Apparatus and Method to Access Bone Marrow,” filed May 30, 2003. U.S. patent application Ser. No. 10/449,476 claims the benefit of U.S. Provisional Patent Application No. 60/384,756, entitled “Apparatus and method to provide access to bone marrow,” filed May 31, 2002. U.S. patent application Ser. No. 11/042,912 claims the benefit of U.S. Provisional Patent Application No. 60/539,171, entitled “Manual Interosseous Device,” filed Jan. 26, 2004, and U.S. Provisional Patent Application No. 60/547,868, entitled “Impact-Driven Interosseous Needle,” filed Feb. 26, 2004.

US Referenced Citations (824)
Number Name Date Kind
1272104 Reithmueller Jul 1918 A
1539637 Bronner et al. May 1925 A
1686482 Windle Oct 1928 A
1954620 Connell Apr 1934 A
2080202 Drake May 1937 A
2130845 Von Issendorff Sep 1938 A
2138842 Drew et al. Dec 1938 A
2219605 Turkel Oct 1940 A
2261958 Burri et al. Nov 1941 A
2317648 Siqveland et al. Apr 1943 A
2318648 Penfold May 1943 A
2419045 Whittaker et al. Apr 1947 A
2426535 Turkel Aug 1947 A
2525588 Cameron et al. Oct 1950 A
2525839 Sparklin Oct 1950 A
2590516 Von Breymann Mar 1952 A
2660635 Wood Nov 1953 A
2714026 Schultz Jul 1955 A
RE24056 Johansen Aug 1955 E
2766907 Wallace, Jr. Oct 1956 A
2773501 Young Dec 1956 A
2817648 Gould et al. Dec 1957 A
2860635 Wilburn et al. Nov 1958 A
2876369 Doerner Mar 1959 A
3022596 Cannon Feb 1962 A
3104448 Morrow et al. Sep 1963 A
3120845 Horner et al. Feb 1964 A
3173417 Horner et al. Mar 1965 A
3175554 Stewart et al. Mar 1965 A
3269046 Schaefer Aug 1966 A
3413498 Bowen et al. Nov 1968 A
3507276 Burgess et al. Apr 1970 A
3519858 Morganson Jul 1970 A
3529580 Stevens et al. Sep 1970 A
3536943 Bowen et al. Oct 1970 A
3543966 Ryan et al. Dec 1970 A
3598108 Jamshidi et al. Aug 1971 A
3664163 Foote May 1972 A
3671699 Matthews Jun 1972 A
3697223 Kovalcik et al. Oct 1972 A
3713417 Shugart Jan 1973 A
3734207 Fishbein May 1973 A
3750667 Pshenichny et al. Aug 1973 A
3802555 Grasty et al. Apr 1974 A
3815605 Schmidt et al. Jun 1974 A
3835860 Garretson Sep 1974 A
3843143 Laxson Oct 1974 A
3844291 Moen Oct 1974 A
3850158 Elias et al. Nov 1974 A
3893445 Hofsess Jul 1975 A
3893455 McNally Jul 1975 A
3935909 Mabuchi et al. Feb 1976 A
3976066 McCartney Aug 1976 A
3981398 Boshoff Sep 1976 A
3991765 Cohen Nov 1976 A
3999110 Ramstrom et al. Dec 1976 A
4021920 Kirschner et al. May 1977 A
4040462 Hattan Aug 1977 A
4046254 Kramer Sep 1977 A
4099518 Baylis et al. Jul 1978 A
4124026 Bemner et al. Nov 1978 A
4142517 Contreras Guerrero de Stavropoulos et al. Mar 1979 A
4154026 Palthe May 1979 A
4157714 Foltz et al. Jun 1979 A
4170993 Alvarez Oct 1979 A
4185619 Reiss Jan 1980 A
4189266 Koslow Feb 1980 A
4194505 Schmitz Mar 1980 A
4200111 Harris Apr 1980 A
4213462 Sato Jul 1980 A
4258722 Sessions et al. Mar 1981 A
4262676 Jamshidi Apr 1981 A
4266555 Jamshidi May 1981 A
4269192 Matsuo May 1981 A
4299230 Kubota Nov 1981 A
4306570 Matthews Dec 1981 A
4316463 Schmitz et al. Feb 1982 A
4330093 Chapman, Jr. May 1982 A
4333459 Becker Jun 1982 A
4334529 Wirth Jun 1982 A
4356826 Kubota Nov 1982 A
4359052 Staub Nov 1982 A
4373518 Kaiser et al. Feb 1983 A
4378053 Simpson Mar 1983 A
4381777 Garnier May 1983 A
4393872 Reznik et al. Jul 1983 A
4399723 Marleau Aug 1983 A
4413760 Paton Nov 1983 A
4416503 Hayes Nov 1983 A
4420085 Wilson et al. Dec 1983 A
4441563 Walton, II Apr 1984 A
4461305 Cibley Jul 1984 A
4469109 Mehl Sep 1984 A
4484577 Sackner et al. Nov 1984 A
4487209 Mehl Dec 1984 A
4504267 Parmelee et al. Mar 1985 A
4522302 Paikoff Jun 1985 A
4543966 Islam et al. Oct 1985 A
4553539 Morris Nov 1985 A
4578064 Sarnoff et al. Mar 1986 A
4595322 Clement Jun 1986 A
4605011 Naslund Aug 1986 A
4620539 Andrews et al. Nov 1986 A
4623335 Jackson Nov 1986 A
4630616 Tretinyak Dec 1986 A
4645492 Weeks Feb 1987 A
4646731 Brower Mar 1987 A
4654030 Moll et al. Mar 1987 A
4654492 Koerner et al. Mar 1987 A
4655226 Lee Apr 1987 A
4659329 Annis Apr 1987 A
4670008 Von Albertini Jun 1987 A
4691929 Neumaier et al. Sep 1987 A
4692073 Martindell Sep 1987 A
4696308 Meller et al. Sep 1987 A
4702261 Cornell et al. Oct 1987 A
4711636 Bierman Dec 1987 A
4713061 Tarello et al. Dec 1987 A
4716901 Jackson et al. Jan 1988 A
4720881 Meyers Jan 1988 A
4723945 Theiling Feb 1988 A
4728876 Mongeon et al. Mar 1988 A
4736850 Bowman et al. Apr 1988 A
4753345 Goodsir et al. Jun 1988 A
4758225 Cox et al. Jul 1988 A
4762118 Lia et al. Aug 1988 A
4772261 Von Hoff et al. Sep 1988 A
4787893 Villette Nov 1988 A
4793363 Ausherman et al. Dec 1988 A
4801293 Jackson Jan 1989 A
4810248 Masters et al. Mar 1989 A
4812008 Tokumaru et al. Mar 1989 A
4838282 Strasser et al. Jun 1989 A
4844259 Glowczewskie et al. Jul 1989 A
4867158 Sugg Sep 1989 A
4874181 Hsu Oct 1989 A
4883470 Haindl Nov 1989 A
4919146 Rhinehart et al. Apr 1990 A
4919653 Martinez et al. Apr 1990 A
4921013 Spalink et al. May 1990 A
4922602 Mehl May 1990 A
4935010 Cox et al. Jun 1990 A
4940459 Noce Jul 1990 A
4944677 Alexandre Jul 1990 A
4969870 Kramer Nov 1990 A
4976269 Mehl Dec 1990 A
4986279 O'Neill Jan 1991 A
5002546 Romano Mar 1991 A
5012605 Nishioka May 1991 A
5025797 Baran Jun 1991 A
5036860 Leigh et al. Aug 1991 A
5040542 Gray Aug 1991 A
5057085 Kopans Oct 1991 A
5064426 Huebsch Nov 1991 A
5074311 Hasson Dec 1991 A
5075994 Nishioka Dec 1991 A
5104382 Brinkerhoff et al. Apr 1992 A
5116324 Brierley et al. May 1992 A
5120312 Wigness et al. Jun 1992 A
5122114 Miller et al. Jun 1992 A
5133359 Kedem Jul 1992 A
5137500 Lhotak Aug 1992 A
5137518 Mersch Aug 1992 A
5139500 Schwartz Aug 1992 A
RE34056 Lindgren et al. Sep 1992 E
5145369 Lustig et al. Sep 1992 A
5148813 Bucalo Sep 1992 A
5156399 Gauer Oct 1992 A
5159163 Bahjat et al. Oct 1992 A
5172700 Bencini et al. Dec 1992 A
5172701 Leigh Dec 1992 A
5172702 Leigh et al. Dec 1992 A
5176415 Choksi Jan 1993 A
5176643 Kramer et al. Jan 1993 A
5183054 Burkholder et al. Feb 1993 A
5184611 Turnbull Feb 1993 A
5187422 Izenbaard et al. Feb 1993 A
5195985 Hall Mar 1993 A
5203056 Funk et al. Apr 1993 A
5204670 Stinton Apr 1993 A
5207303 Oswalt et al. May 1993 A
5207697 Carusillo et al. May 1993 A
5209721 Wilk May 1993 A
5210376 Caviar May 1993 A
5217478 Rexroth Jun 1993 A
D338270 Stephens Aug 1993 S
5244619 Burnham Sep 1993 A
5249583 Mallaby Oct 1993 A
5257632 Turkel et al. Nov 1993 A
5257972 Gurmarnik Nov 1993 A
5261877 Fine et al. Nov 1993 A
5261891 Brinkerhoff et al. Nov 1993 A
5269785 Bonutti Dec 1993 A
5271380 Riek et al. Dec 1993 A
5271414 Partika et al. Dec 1993 A
5271744 Kramer et al. Dec 1993 A
5279306 Mehl Jan 1994 A
5300070 Gentelia et al. Apr 1994 A
5312351 Gerrone May 1994 A
5312361 Zadini et al. May 1994 A
5312364 Jacobs May 1994 A
5312408 Brown May 1994 A
5313733 Meade May 1994 A
5315737 Ouimet May 1994 A
5318543 Ross et al. Jun 1994 A
5318589 Lichtman Jun 1994 A
5320110 Wang Jun 1994 A
5324300 Elias et al. Jun 1994 A
5330480 Meloul et al. Jul 1994 A
5331972 Wadhwani et al. Jul 1994 A
5332398 Miller et al. Jul 1994 A
5333790 Christopher Aug 1994 A
5334169 Brown et al. Aug 1994 A
5334204 Clewett et al. Aug 1994 A
5339831 Thompson Aug 1994 A
5341316 Nishigaki Aug 1994 A
5341816 Allen Aug 1994 A
5341823 Manosalva et al. Aug 1994 A
5344420 Hilal et al. Sep 1994 A
5348022 Leigh et al. Sep 1994 A
5356006 Alpern et al. Oct 1994 A
5357974 Baldridge Oct 1994 A
5357979 Imran Oct 1994 A
5361853 Takamura et al. Nov 1994 A
5366445 Haber et al. Nov 1994 A
5368046 Scarfone et al. Nov 1994 A
5372583 Roberts et al. Dec 1994 A
5383859 Sewell, Jr. Jan 1995 A
5385151 Scarfone et al. Jan 1995 A
5385553 Hart et al. Jan 1995 A
5389553 Grubisich et al. Feb 1995 A
5400798 Baran Mar 1995 A
5405348 Anspach, Jr. et al. Apr 1995 A
5405362 Kramer et al. Apr 1995 A
5407243 Riemann Apr 1995 A
5421821 Janicki et al. Jun 1995 A
5423796 Shikhman et al. Jun 1995 A
5423824 Akerfeldt et al. Jun 1995 A
5431151 Riek et al. Jul 1995 A
5431655 Melker et al. Jul 1995 A
5432459 Thompson et al. Jul 1995 A
5436566 Thompson et al. Jul 1995 A
5437119 Womack Aug 1995 A
5449370 Vaitekunas Sep 1995 A
5451210 Kramer et al. Sep 1995 A
5454791 Tovey et al. Oct 1995 A
5462062 Rubinstein et al. Oct 1995 A
5476102 Como et al. Dec 1995 A
5480388 Zadini et al. Jan 1996 A
5484442 Melker et al. Jan 1996 A
5497787 Nemesdy et al. Mar 1996 A
5499997 Sharpe et al. Mar 1996 A
5505737 Gosselin et al. Apr 1996 A
D369858 Baker et al. May 1996 S
5514097 Knauer May 1996 A
5526820 Khoury Jun 1996 A
5526821 Jamshidi Jun 1996 A
5526822 Burbank et al. Jun 1996 A
5527290 Zadini et al. Jun 1996 A
5529580 Kusunoki et al. Jun 1996 A
5533843 Chung Jul 1996 A
5549565 Ryan et al. Aug 1996 A
5554154 Rosenberg Sep 1996 A
5556399 Huebner Sep 1996 A
5558737 Brown et al. Sep 1996 A
5571133 Yoon Nov 1996 A
5586847 Mattern, Jr. et al. Dec 1996 A
5591119 Adair Jan 1997 A
5591188 Waisman Jan 1997 A
5595186 Rubinstein et al. Jan 1997 A
5599347 Hart et al. Feb 1997 A
5599348 Gentelia et al. Feb 1997 A
5601559 Melker et al. Feb 1997 A
5624214 Carroll Apr 1997 A
5632747 Scarborough et al. May 1997 A
5649547 Ritchart et al. Jul 1997 A
5651419 Holzer et al. Jul 1997 A
5672155 Riley et al. Sep 1997 A
5685820 Riek et al. Nov 1997 A
5687802 Spooner et al. Nov 1997 A
5693031 Ryan et al. Dec 1997 A
5709275 Neumaier Jan 1998 A
5712543 Sjostrom Jan 1998 A
5713149 Cady et al. Feb 1998 A
5713368 Leigh Feb 1998 A
5724873 Hillinger Mar 1998 A
5733262 Paul Mar 1998 A
5738177 Schell et al. Apr 1998 A
5752923 Terwilliger May 1998 A
5762498 Gonzalez Jun 1998 A
5762639 Gibbs Jun 1998 A
5766221 Benderev et al. Jun 1998 A
5769086 Ritchart et al. Jun 1998 A
5779708 Wu Jul 1998 A
5800389 Burney et al. Sep 1998 A
5801454 Leininger Sep 1998 A
5807275 Jamshidi Sep 1998 A
5807277 Swaim Sep 1998 A
5809653 Everts et al. Sep 1998 A
5810826 Akerfeldt et al. Sep 1998 A
5817052 Johnson et al. Oct 1998 A
5823970 Terwilliger Oct 1998 A
D403405 Terwilliger Dec 1998 S
D404458 Pruitt Jan 1999 S
5858005 Kriesel Jan 1999 A
5865711 Chen Feb 1999 A
5868711 Kramer et al. Feb 1999 A
5868750 Schultz Feb 1999 A
5873499 Leschinsky et al. Feb 1999 A
5873510 Hirai et al. Feb 1999 A
5873580 Swenson et al. Feb 1999 A
5885226 Rubinstein et al. Mar 1999 A
5891085 Lilley et al. Apr 1999 A
5893851 Umber et al. Apr 1999 A
5906797 Orihara et al. May 1999 A
5910121 Avaltroni et al. Jun 1999 A
5911701 Miller et al. Jun 1999 A
5911708 Teirstein Jun 1999 A
5916229 Evans Jun 1999 A
5919172 Golba, Jr. Jul 1999 A
5921562 Robison Jul 1999 A
5921987 Stone Jul 1999 A
5924864 Loge et al. Jul 1999 A
5926989 Oliver, Sr. Jul 1999 A
5927976 Wu Jul 1999 A
5928164 Burbank et al. Jul 1999 A
5928238 Scarborough et al. Jul 1999 A
5928241 Menut et al. Jul 1999 A
5938636 Kramer et al. Aug 1999 A
5941706 Ura Aug 1999 A
5941841 Mutch et al. Aug 1999 A
5941851 Coffey et al. Aug 1999 A
5947989 Shikhman et al. Sep 1999 A
5951026 Harman, Jr. et al. Sep 1999 A
5954671 O'Neill Sep 1999 A
5954701 Matalon Sep 1999 A
5960575 Chiovitt et al. Oct 1999 A
5960797 Kramer et al. Oct 1999 A
5980469 Burbank et al. Nov 1999 A
5980545 Pacala et al. Nov 1999 A
5984020 Meyer et al. Nov 1999 A
5984919 Hilal et al. Nov 1999 A
5989257 Tidwell et al. Nov 1999 A
5993417 Yerfino et al. Nov 1999 A
5993454 Longo Nov 1999 A
6007481 Riek et al. Dec 1999 A
6007496 Brannon Dec 1999 A
6015391 Rishton et al. Jan 2000 A
6017348 Hart et al. Jan 2000 A
6018094 Fox Jan 2000 A
6018230 Casey Jan 2000 A
6022324 Skinner Feb 2000 A
6025683 Philipp Feb 2000 A
6027458 Janssens Feb 2000 A
6033369 Goldenberg Mar 2000 A
6033408 Gage et al. Mar 2000 A
6033411 Preissman Mar 2000 A
6042585 Norman Mar 2000 A
6049725 Emmert et al. Apr 2000 A
6050754 Thomas Apr 2000 A
6059806 Hoegerle May 2000 A
6063037 Mittermeier et al. May 2000 A
6066938 Hyodo et al. May 2000 A
6071284 Fox Jun 2000 A
6080115 Rubinstein Jun 2000 A
6083176 Terwilliger Jul 2000 A
6086543 Anderson et al. Jul 2000 A
6086544 Hibner et al. Jul 2000 A
6092355 Ishmael Jul 2000 A
6096042 Herbert Aug 2000 A
6098042 Huynh Aug 2000 A
6102887 Altman Aug 2000 A
6102915 Bresler et al. Aug 2000 A
6106484 Terwilliger Aug 2000 A
6110128 Andelin et al. Aug 2000 A
6110129 Terwilliger Aug 2000 A
6110174 Nichter Aug 2000 A
6120462 Hibner et al. Sep 2000 A
6126670 Walker et al. Oct 2000 A
6129106 Kornelson et al. Oct 2000 A
6135769 Kwan Oct 2000 A
6152918 Padilla et al. Nov 2000 A
6154995 Lenoir et al. Dec 2000 A
6159163 Strauss et al. Dec 2000 A
6162203 Haaga Dec 2000 A
6171276 Lippe et al. Jan 2001 B1
6183442 Athanasiou et al. Feb 2001 B1
6187768 Welle et al. Feb 2001 B1
6210376 Grayson Apr 2001 B1
6217561 Gibbs Apr 2001 B1
6221029 Mathis et al. Apr 2001 B1
6228049 Schroeder et al. May 2001 B1
6228088 Miller et al. May 2001 B1
6231996 Umeno et al. May 2001 B1
6238355 Daum May 2001 B1
6241734 Scribner et al. Jun 2001 B1
6242009 Batarseh et al. Jun 2001 B1
6247110 Huppenthal et al. Jun 2001 B1
6247928 Meller et al. Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6257351 Ark et al. Jul 2001 B1
6261272 Gross et al. Jul 2001 B1
6267763 Castro Jul 2001 B1
6270087 Mickel et al. Aug 2001 B1
6272007 Kitlas et al. Aug 2001 B1
6273715 Meller et al. Aug 2001 B1
6273862 Privitera et al. Aug 2001 B1
6283925 Terwilliger Sep 2001 B1
6283970 Lubinus Sep 2001 B1
6287114 Meller et al. Sep 2001 B1
6302409 Gutsche Oct 2001 B1
6302852 Fleming, III et al. Oct 2001 B1
6308540 Lee Oct 2001 B1
6309258 Measley Oct 2001 B1
6309358 Okubo Oct 2001 B1
6312394 Fleming, III Nov 2001 B1
6315737 Skinner Nov 2001 B1
6321855 Barnes Nov 2001 B1
6325806 Fox Dec 2001 B1
6328701 Terwilliger Dec 2001 B1
6328744 Harari et al. Dec 2001 B1
6349496 Neely Feb 2002 B1
6358252 Shapira Mar 2002 B1
6382212 Borchard May 2002 B1
6402701 Kaplan et al. Jun 2002 B1
6416484 Miller et al. Jul 2002 B1
6419490 Kitchings Weathers, Jr. Jul 2002 B1
6425388 Korinchock Jul 2002 B1
6425888 Embleton et al. Jul 2002 B1
6428487 Burdorff et al. Aug 2002 B1
6443910 Krueger et al. Sep 2002 B1
6446734 Williams et al. Sep 2002 B1
6450973 Murphy Sep 2002 B1
6451023 Salazar et al. Sep 2002 B1
6458117 Pollins, Sr. Oct 2002 B1
6468248 Gibbs Oct 2002 B1
6478751 Krueger et al. Nov 2002 B1
6488636 Bryan et al. Dec 2002 B2
6494590 Paganini et al. Dec 2002 B1
6523698 Dennehey et al. Feb 2003 B1
6527736 Attinger et al. Mar 2003 B1
6527778 Athanasiou et al. Mar 2003 B2
6540694 Van Bladel et al. Apr 2003 B1
6540697 Chen Apr 2003 B2
6547451 Nishikawa et al. Apr 2003 B1
6547511 Adams Apr 2003 B1
6547561 Meller et al. Apr 2003 B2
6547755 Lippe et al. Apr 2003 B1
6549511 Prikryl Apr 2003 B1
6550786 Gifford et al. Apr 2003 B2
6554779 Viola et al. Apr 2003 B2
6555212 Boiocchi et al. Apr 2003 B2
6572563 Ouchi Jun 2003 B2
6575745 Meller et al. Jun 2003 B2
6575919 Reiley et al. Jun 2003 B1
6582399 Smith et al. Jun 2003 B1
6585622 Shum et al. Jul 2003 B1
6595362 Penney et al. Jul 2003 B2
6595911 LoVuolo Jul 2003 B2
6595979 Epstein et al. Jul 2003 B1
6613054 Scribner et al. Sep 2003 B2
6616632 Sharp et al. Sep 2003 B2
6620111 Stephens et al. Sep 2003 B2
6622731 Daniel et al. Sep 2003 B2
6626173 Genova et al. Sep 2003 B2
6626848 Neuenfeldt Sep 2003 B2
6626887 Wu Sep 2003 B1
6638235 Miller et al. Oct 2003 B2
6641395 Kumar et al. Nov 2003 B2
6656133 Voegele et al. Dec 2003 B2
6689072 Kaplan et al. Feb 2004 B2
6690308 Hayami Feb 2004 B2
6702760 Krause et al. Mar 2004 B2
6702761 Damadian et al. Mar 2004 B1
6706016 Cory et al. Mar 2004 B2
6716192 Orosz, Jr. Apr 2004 B1
6716215 David et al. Apr 2004 B1
6716216 Boucher et al. Apr 2004 B1
6726649 Swenson et al. Apr 2004 B2
6730043 Krueger et al. May 2004 B2
6730044 Stephens et al. May 2004 B2
6749576 Bauer Jun 2004 B2
6752768 Burdorff et al. Jun 2004 B2
6752816 Culp et al. Jun 2004 B2
6758824 Miller et al. Jul 2004 B1
6761726 Findlay et al. Jul 2004 B1
6770070 Balbierz Aug 2004 B1
6783532 Steiner et al. Aug 2004 B2
6796957 Carpenter et al. Sep 2004 B2
6839789 Kraemer et al. Jan 2005 B2
6846314 Shapira Jan 2005 B2
6849051 Sramek et al. Feb 2005 B2
6855148 Foley et al. Feb 2005 B2
6860860 Viola Mar 2005 B2
6871759 Rake et al. Mar 2005 B2
6872187 Stark et al. Mar 2005 B1
6875163 Cercone et al. Apr 2005 B2
6875183 Cervi Apr 2005 B2
6875219 Arramon et al. Apr 2005 B2
6884245 Spranza, III Apr 2005 B2
6887209 Kadziauskas et al. May 2005 B2
6890308 Islam May 2005 B2
6896141 McMichael et al. May 2005 B2
6902559 Taufig Jun 2005 B2
6905466 Salgo et al. Jun 2005 B2
6905486 Gibbs Jun 2005 B2
6916292 Morawski et al. Jul 2005 B2
6930461 Rutkowski Aug 2005 B2
6942669 Kurc Sep 2005 B2
6947669 Wu et al. Sep 2005 B2
6969373 Schwartz et al. Nov 2005 B2
7001342 Faciszewski Feb 2006 B2
7008381 Janssens Mar 2006 B2
7008383 Damadian et al. Mar 2006 B1
7008394 Geise et al. Mar 2006 B2
7014614 Casula Mar 2006 B2
7018343 Plishka Mar 2006 B2
7025732 Thompson et al. Apr 2006 B2
7033324 Giusti et al. Apr 2006 B2
7063672 Schramm Jun 2006 B2
7063703 Reo Jun 2006 B2
7081123 Merboth et al. Jul 2006 B2
7108696 Daniel et al. Sep 2006 B2
7134815 Steer Nov 2006 B2
7137985 Jahng Nov 2006 B2
7169127 Epstein et al. Jan 2007 B2
7182752 Stubbs et al. Feb 2007 B2
7186257 Kim Mar 2007 B2
7207949 Miles et al. Apr 2007 B2
7212011 Shimizu et al. May 2007 B2
7226450 Athanasiou et al. Jun 2007 B2
7229401 Kindlein Jun 2007 B2
7278972 Lamoureux et al. Oct 2007 B2
7285112 Stubbs et al. Oct 2007 B2
7331462 Steppe Feb 2008 B2
7331930 Faciszewski Feb 2008 B2
7338473 Campbell et al. Mar 2008 B2
7413559 Stubbs et al. Aug 2008 B2
7513722 Greenberg et al. Apr 2009 B2
7565935 Phillips Jul 2009 B1
7615043 Zhou Nov 2009 B2
7670328 Miller Mar 2010 B2
7699850 Miller Apr 2010 B2
7736322 Roe et al. Jun 2010 B2
7798331 Hardin et al. Sep 2010 B2
7811260 Miller et al. Oct 2010 B2
7815642 Miller Oct 2010 B2
7850620 Miller et al. Dec 2010 B2
7854724 Stearns et al. Dec 2010 B2
7899528 Miller et al. Mar 2011 B2
7934333 Tuz May 2011 B1
7951089 Miller May 2011 B2
7988643 Hoffmann et al. Aug 2011 B2
8038664 Miller et al. Oct 2011 B2
8088189 Matula et al. Jan 2012 B2
8092457 Oettinger et al. Jan 2012 B2
8142365 Miller Mar 2012 B2
8216189 Stubbs et al. Jul 2012 B2
8217561 Fukuzawa et al. Jul 2012 B2
8277411 Gellman Oct 2012 B2
8282565 Mahapatra et al. Oct 2012 B2
8308693 Miller et al. Nov 2012 B2
8317815 Mastri et al. Nov 2012 B2
8419683 Miller et al. Apr 2013 B2
8480632 Miller et al. Jul 2013 B2
8506568 Miller Aug 2013 B2
8641715 Miller Feb 2014 B2
8656929 Miller et al. Feb 2014 B2
8668698 Miller et al. Mar 2014 B2
8684978 Miller et al. Apr 2014 B2
8690791 Miller Apr 2014 B2
8715219 Stearns et al. May 2014 B2
8715287 Miller May 2014 B2
8720097 Derman May 2014 B2
8812101 Miller et al. Aug 2014 B2
8814807 Hulvershorn et al. Aug 2014 B2
8870872 Miller Oct 2014 B2
8876826 Miller Nov 2014 B2
8920388 Slocum et al. Dec 2014 B2
8926525 Hulvershorn et al. Jan 2015 B2
8944069 Miller et al. Feb 2015 B2
8961451 Stearns et al. Feb 2015 B2
8974410 Miller et al. Mar 2015 B2
8974569 Matula et al. Mar 2015 B2
8992535 Miller Mar 2015 B2
8998348 Frank Apr 2015 B2
8998848 Miller et al. Apr 2015 B2
9067030 Stearns et al. Jun 2015 B2
9072543 Miller et al. Jul 2015 B2
9078637 Miller Jul 2015 B2
9095372 Stearns et al. Aug 2015 B2
9110104 Chung et al. Aug 2015 B2
9186172 Velez Rivera Nov 2015 B2
9199047 Stearns et al. Dec 2015 B2
9295487 Miller et al. Mar 2016 B2
9314270 Miller Apr 2016 B2
9439667 Miller Sep 2016 B2
9451968 Miller et al. Sep 2016 B2
9504477 Miller et al. Nov 2016 B2
9545243 Miller et al. Jan 2017 B2
9662160 Beale et al. May 2017 B2
9717564 Miller et al. Aug 2017 B2
9717847 Miller et al. Aug 2017 B2
9826984 McGinley et al. Nov 2017 B2
9872703 Miller et al. Jan 2018 B2
10016217 Miller Jul 2018 B2
10052111 Miller et al. Aug 2018 B2
10245010 Miller et al. Apr 2019 B2
10258783 Miller et al. Apr 2019 B2
10456149 Miller Oct 2019 B2
10512474 Miller et al. Dec 2019 B2
10806491 Miller et al. Oct 2020 B2
10893875 Miller Jan 2021 B2
11103281 Miller Aug 2021 B2
11103282 Miller Aug 2021 B1
20010005778 Ouchi Jun 2001 A1
20010014439 Meller et al. Aug 2001 A1
20010026051 Gifford et al. Oct 2001 A1
20010034527 Scribner et al. Oct 2001 A1
20010047183 Privitera et al. Nov 2001 A1
20010053888 Athanasiou et al. Dec 2001 A1
20020018102 Nozawa Feb 2002 A1
20020029007 Bryan et al. Mar 2002 A1
20020042581 Cervi Apr 2002 A1
20020050364 Suzuki et al. May 2002 A1
20020055713 Gibbs May 2002 A1
20020091039 Reinbold et al. Jul 2002 A1
20020096343 Potter et al. Jul 2002 A1
20020120212 Ritchart et al. Aug 2002 A1
20020133148 Daniel et al. Sep 2002 A1
20020138021 Pflueger Sep 2002 A1
20020143269 Neuenfeldt Oct 2002 A1
20020151821 Castellacci Oct 2002 A1
20020151902 Riedel et al. Oct 2002 A1
20020158102 Patton et al. Oct 2002 A1
20030009132 Schwartz et al. Jan 2003 A1
20030023256 Estes et al. Jan 2003 A1
20030028146 Aves Feb 2003 A1
20030032939 Gibbs Feb 2003 A1
20030036747 Ie et al. Feb 2003 A1
20030050574 Krueger Mar 2003 A1
20030078586 Shapira Apr 2003 A1
20030078589 Preissman Apr 2003 A1
20030114858 Athanasiou et al. Jun 2003 A1
20030125639 Fisher et al. Jul 2003 A1
20030144104 Ryberg Jul 2003 A1
20030149436 McDowell et al. Aug 2003 A1
20030153842 Lamoureux et al. Aug 2003 A1
20030173178 Sasaki Sep 2003 A1
20030191414 Reiley et al. Oct 2003 A1
20030195436 Van Bladel et al. Oct 2003 A1
20030195524 Barner Oct 2003 A1
20030199787 Schwindt Oct 2003 A1
20030199879 Spranza Oct 2003 A1
20030205987 Barlev et al. Nov 2003 A1
20030212343 Plishka Nov 2003 A1
20030216667 Viola Nov 2003 A1
20030225344 Miller Dec 2003 A1
20030225364 Kraft et al. Dec 2003 A1
20030225411 Miller Dec 2003 A1
20030233114 Merboth et al. Dec 2003 A1
20040010236 Morawski et al. Jan 2004 A1
20040019297 Angel Jan 2004 A1
20040019299 Ritchart et al. Jan 2004 A1
20040031721 Mann Feb 2004 A1
20040032179 Du Feb 2004 A1
20040034280 Privitera et al. Feb 2004 A1
20040049128 Miller et al. Mar 2004 A1
20040049205 Lee et al. Mar 2004 A1
20040064136 Papineau et al. Apr 2004 A1
20040073139 Hirsch et al. Apr 2004 A1
20040092946 Bagga et al. May 2004 A1
20040127814 Negroni Jul 2004 A1
20040153003 Cicenas et al. Aug 2004 A1
20040158172 Hancock Aug 2004 A1
20040158173 Voegele et al. Aug 2004 A1
20040162505 Kaplan et al. Aug 2004 A1
20040167428 Quick et al. Aug 2004 A1
20040191897 Muschler Sep 2004 A1
20040210161 Burdorff et al. Oct 2004 A1
20040210196 Bush et al. Oct 2004 A1
20040210198 Shih Oct 2004 A1
20040215102 Ikehara et al. Oct 2004 A1
20040220497 Findlay et al. Nov 2004 A1
20040249306 Islam Dec 2004 A1
20040249389 Kim Dec 2004 A1
20040259254 Honmou et al. Dec 2004 A1
20050027210 Miller Feb 2005 A1
20050033275 Hoegerle et al. Feb 2005 A1
20050033304 O'Heeron Feb 2005 A1
20050040060 Andersen et al. Feb 2005 A1
20050043714 Zhou Feb 2005 A1
20050075581 Schwindt Apr 2005 A1
20050085838 Thompson et al. Apr 2005 A1
20050101880 Cicenas et al. May 2005 A1
20050113716 Mueller, Jr. et al. May 2005 A1
20050116673 Carl et al. Jun 2005 A1
20050119660 Bourlion et al. Jun 2005 A1
20050124915 Eggers et al. Jun 2005 A1
20050131345 Miller Jun 2005 A1
20050148940 Miller Jul 2005 A1
20050159677 Shabaz et al. Jul 2005 A1
20050165328 Heske et al. Jul 2005 A1
20050165403 Miller Jul 2005 A1
20050165404 Miller Jul 2005 A1
20050171504 Miller Aug 2005 A1
20050182394 Spero et al. Aug 2005 A1
20050200087 Vasudeva et al. Sep 2005 A1
20050203439 Heske et al. Sep 2005 A1
20050209530 Pflueger Sep 2005 A1
20050215921 Hibner et al. Sep 2005 A1
20050228309 Fisher et al. Oct 2005 A1
20050236940 Rockoff Oct 2005 A1
20050261693 Miller et al. Nov 2005 A1
20060011506 Riley Jan 2006 A1
20060015066 Turieo et al. Jan 2006 A1
20060036212 Miller Feb 2006 A1
20060043685 Kozak Mar 2006 A1
20060052790 Miller Mar 2006 A1
20060074345 Hibner Apr 2006 A1
20060074425 Sutterlin et al. Apr 2006 A1
20060079774 Anderson Apr 2006 A1
20060089565 Schramm Apr 2006 A1
20060111724 Yeung Wai Ping May 2006 A1
20060115066 Levien et al. Jun 2006 A1
20060122535 Daum Jun 2006 A1
20060129082 Rozga Jun 2006 A1
20060144548 Beckman et al. Jul 2006 A1
20060149163 Hibner et al. Jul 2006 A1
20060151188 Bodine et al. Jul 2006 A1
20060167377 Ritchart et al. Jul 2006 A1
20060167378 Miller Jul 2006 A1
20060167379 Miller Jul 2006 A1
20060173480 Zhang Aug 2006 A1
20060184063 Miller Aug 2006 A1
20060189940 Kirsch Aug 2006 A1
20060192350 Kleine et al. Aug 2006 A1
20060206132 Conquergood et al. Sep 2006 A1
20060237205 Sia et al. Oct 2006 A1
20070016100 Miller Jan 2007 A1
20070024013 Hauptmann et al. Feb 2007 A1
20070049945 Miller Mar 2007 A1
20070084742 Miller et al. Apr 2007 A1
20070120331 Manschitz et al. May 2007 A1
20070149920 Michels et al. Jun 2007 A1
20070209957 Glenn et al. Sep 2007 A1
20070213735 Saadat et al. Sep 2007 A1
20070256914 Lohr et al. Nov 2007 A1
20070270712 Wiksell et al. Nov 2007 A1
20070270775 Miller et al. Nov 2007 A1
20080015467 Miller Jan 2008 A1
20080015468 Miller Jan 2008 A1
20080015623 Deck Jan 2008 A1
20080045857 Miller et al. Feb 2008 A1
20080045860 Miller et al. Feb 2008 A1
20080045861 Miller et al. Feb 2008 A1
20080045965 Miller et al. Feb 2008 A1
20080072719 Kozak Mar 2008 A1
20080086160 Mastri et al. Apr 2008 A1
20080087448 Happ Apr 2008 A1
20080140014 Miller et al. Jun 2008 A1
20080177200 Ikehara et al. Jul 2008 A1
20080215056 Miller et al. Sep 2008 A1
20080221580 Miller et al. Sep 2008 A1
20080243163 Masseglia et al. Oct 2008 A1
20080262383 Routhier et al. Oct 2008 A1
20080302551 Komuro et al. Dec 2008 A1
20090069716 Freeman et al. Mar 2009 A1
20090093677 Smith Apr 2009 A1
20090131832 Sacristan et al. May 2009 A1
20090194446 Miller et al. Aug 2009 A1
20090248029 Paulos Oct 2009 A1
20090311061 Santamarina et al. Dec 2009 A1
20100137740 Miller Jun 2010 A1
20100204611 Zambelli Aug 2010 A1
20100298784 Miller Nov 2010 A1
20110046477 Hulvershorn et al. Feb 2011 A1
20110046507 Herndon Feb 2011 A1
20110071572 Sixto et al. Mar 2011 A1
20110082387 Miller et al. Apr 2011 A1
20110098604 Miller Apr 2011 A1
20110125084 Stearns et al. May 2011 A1
20110184425 Cheraux Jul 2011 A1
20110186456 Bertazzoni et al. Aug 2011 A1
20110203821 Puzio et al. Aug 2011 A1
20110251518 Swisher et al. Oct 2011 A1
20110288405 Razavi et al. Nov 2011 A1
20110306841 Lozman et al. Dec 2011 A1
20120109061 Miller et al. May 2012 A1
20120150101 Stearns et al. Jun 2012 A1
20120165832 Oostman et al. Jun 2012 A1
20120283582 Mahapatra et al. Nov 2012 A1
20120323071 Gellman Dec 2012 A1
20120330184 Mahapatra et al. Dec 2012 A1
20130213843 Knight et al. Aug 2013 A1
20140005657 Brannan et al. Jan 2014 A1
20140188038 Stearns et al. Jul 2014 A1
20140231302 Goyal Aug 2014 A1
20140262408 Woodard Sep 2014 A1
20140311302 Taguchi et al. Oct 2014 A1
20140336567 Stearns et al. Nov 2014 A1
20140343454 Miller et al. Nov 2014 A1
20140358070 Stearns et al. Dec 2014 A1
20150025363 Hulvershorn et al. Jan 2015 A1
20150057530 Roggeveen et al. Feb 2015 A1
20150112261 Bassett et al. Apr 2015 A1
20150127006 Miller May 2015 A1
20150129456 Miller et al. May 2015 A1
20150173818 Baroud et al. Jun 2015 A1
20150202390 Stearns et al. Jul 2015 A1
20150202391 Stearns et al. Jul 2015 A1
20150223786 Morgan et al. Aug 2015 A1
20150230823 Morgan et al. Aug 2015 A1
20150342635 Tsamir et al. Dec 2015 A1
20150366569 Miller Dec 2015 A1
20160081732 Baroud Mar 2016 A1
20170036328 Chen Feb 2017 A1
20170266790 Chuang Sep 2017 A1
20180056095 Messerly et al. Mar 2018 A1
20180353191 Miller et al. Dec 2018 A1
20200054350 Miller Feb 2020 A1
20200214722 Miller Jul 2020 A1
20210045753 Miller et al. Feb 2021 A1
20210052286 Miller et al. Feb 2021 A1
Foreign Referenced Citations (64)
Number Date Country
2138842 Jun 1996 CA
2366676 Sep 2000 CA
2454600 Feb 2003 CA
2294028 Oct 1998 CN
2320209 May 1999 CN
2664675 Dec 2004 CN
10057831 May 2002 DE
10057931 Aug 2002 DE
0271775 Jun 1988 EP
0517000 Dec 1992 EP
0807412 Nov 1997 EP
0853349 Jul 1998 EP
1099450 May 2001 EP
1314452 May 2003 EP
1421907 May 2004 EP
1447050 Aug 2004 EP
2068725 Jun 2009 EP
2177171 Aug 2012 EP
3153116 Apr 2017 EP
853349 Mar 1940 FR
2457105 Dec 1980 FR
2516386 May 1983 FR
2931451 Nov 2009 FR
0629824 Sep 1949 GB
2099703 Dec 1982 GB
2130890 Jun 1984 GB
59119808 Aug 1984 JP
61-032633 Sep 1986 JP
6132663 Sep 1986 JP
64-052433 Feb 1989 JP
1052433 Feb 1989 JP
06-132663 May 1994 JP
10-052433 Feb 1998 JP
2001505076 Apr 2001 JP
6132663 May 2017 JP
9208410 May 1992 WO
9307819 Apr 1993 WO
9325151 Dec 1993 WO
9407553 Apr 1994 WO
9631164 Oct 1996 WO
9806337 Feb 1998 WO
9852638 Nov 1998 WO
9918866 Apr 1999 WO
9952444 Oct 1999 WO
0009024 Feb 2000 WO
0010465 Mar 2000 WO
0056220 Sep 2000 WO
200178590 Oct 2001 WO
0193931 Dec 2001 WO
0241791 May 2002 WO
0241792 May 2002 WO
02096497 Dec 2002 WO
0315637 Feb 2003 WO
2003101307 Dec 2003 WO
2005072625 Aug 2005 WO
2005110259 Nov 2005 WO
2005112800 Dec 2005 WO
2008033871 Mar 2008 WO
2008033874 Mar 2008 WO
2008081438 Jul 2008 WO
2009070896 Jun 2009 WO
2011070593 Jun 2011 WO
2011123703 Oct 2011 WO
2012175946 Dec 2012 WO
Non-Patent Literature Citations (214)
Entry
Australian Exam Report on Patent Application No. 2003240970, 2 pages, dated Oct. 15, 2007.
Chineese Office Action with English translation; Application No. 200910006631.3; pp. 12, dated Mar. 11, 2010.
Chinese Office Action w/english translation; Application No. 200680021872.X; pp. 8, dated Nov. 6, 2009.
Chinese Office Action with English translation, Application No. 2005800003261, 9 pgs, dated Jan. 16, 2009.
Chinese Office Action with English translation; Application No. 200380000022.0; pp. 10; dated Dec. 13, 2010.
Chinese Office Action with English translation; Application No. 200780000585.5; pp. 15, dated Nov. 19, 2010.
Chinese Office Action with English translation; Application No. 200780001190. 7; 12 pgs., dated Jun. 2, 2010.
Chinese Office Action with English translation; Application No. 200780001196; 12 pgs., dated Jul. 12, 2010.
Chinese Office Action with English translation; Application No. 200780001198.3; pp. 13, dated Apr. 27, 2010.
Chinese Office Action with English translation; Application No. 200830000022.0; pp. dated May 25, 2012.
Chinese Office Action with English translation; Application No. 200880000022.0; Pgs, dated Sep. 22, 2011.
Chinese Office Action with English translation; Application No. 200880000182.5; 12 pages, dated Sep. 10, 2010.
Chinese Office Action with English translation; Application No. 200910006631.3; pp. 9, dated Nov. 11, 2010.
Chinese Office Action, Application No. 200780000590.6, (with English translation), (13 pages), dated Aug. 21, 2009.
Chinese Office Action, Application No. 200780001188.X, (with English translation), (8 pgs) dated Nov. 9, 2010.
Chinese Office Action, Notification of the Fourth Office Action, Application No. 200880000022.0, dated Jan. 7, 2013.
Chinese Office Action, Notification of the Second Office Action, Application No. 200780000590.6, dated Mar. 1, 2010.
Communication Pursuant to Article 94(3) EPC in European Application No. 05712091.7 dated Apr. 8, 2008.
Communication relating to the results of the partial International Search Report for Mailed PCT/US2005/002484, 6 pages dated May 19, 2005.
Edited by Frederick A. Matsen III M.D., Comparlmental Syndromes, About Compartmental Syndromes, Generic Trauma Content http://www.orthop.washington.edu/uw/ . . . , pp. 1-45.
European Extended Search Report, Application No. EP08021732.6, 7 pages, dated Nov. 13, 2009.
European Extended Search Report, Application No. EP10153350.3, 5 pages, dated Mar. 11, 2010.
European Office Action and Search Report, Application No. 09150973. 7, 8 pages, dated Oct. 23, 2009.
European Office Action dated Apr. 8, 2008 and Response dated May 15, 2008 , EP Application No. 05712091.7.
European Office Action dated Dec. 22, 2011 and Response dated Jun. 29, 2012 , EP Application No. 09150973.7.
European Office Action dated Feb. 21, 2007 and Response dated Jun. 27, 2007 , EP Application No. 05712091.7.
European Office Action dated Jan. 19, 2011 and Response dated Jul. 21, 2011 , EP Application No. 09150973.7.
European Office Action dated Sep. 21, 2007 and Response dated Nov. 26, 2007, EP Application No. 05712091.7.
European Office Action dated Sep. 8, 2010 and Response sent Mar. 17, 2011, EP Application No. 10153350.3.
European Office Action, Application No. 10 153 350.3, 5 pages, dated Sep. 8, 2010.
European Patent Office, Communication from Examining Division for European Patent Application No. 08799753.2, dated Apr. 10, 2014.
European Patent Office, Communication from Examining Division for European Patent Application No. 08799753.2, dated May 18, 2015.
European Patent Office, Communication from Examining Division for European Patent Application No. 08799753.2, dated Sep. 29, 2014.
European Patent Office, European Search Report for European Patent Application No. 08799753.2, dated May 23, 2013.
European Search Report for European Patent Application No. 07842288.8, dated Mar. 16, 2011.
European Search Report issued in European Patent Application No. 17198059.2 dated Jan. 29, 2018.
European Telephone Consultation Report dated Apr. 21, 2009 and Response dated Jun. 24, 2009 , EP Application No. 08158699 .2.
European Telephone Consultation Report dated Sep. 23, 2009 and Response dated Oct. 28, 2009 , EP Application No. 08158699 .2.
Extended European Search Report for European application 07842285.4, dated Mar. 17, 2011.
Extended European Search Report for European application 07842286.2, dated Mar. 18, 2011.
Extended European Search Report in Application No. EP 10153350.3 dated Mar. 11, 2010.
Final Office Action, U.S. Appl. No. 11/064,156, 12 pages, dated Jun. 19, 2009.
Final Office Action, U.S. Appl. No. 11/781,568, 19 pages, dated Jun. 17, 2009.
Final Office Action, U.S. Appl. No. 11/781,597, 14 pages, dated Nov. 17, 2009.
Final Office Action, U.S. Appl. No. 11/853,685, 21 pages, dated Jun. 24, 2009.
International PCT Search Report and Written Opinion PCT /US2005/002484, 15 pages, dated Jul. 22, 2005.
International PCT Search Report and Written Opinion PCT/US2004/037753, 16 pages, dated Jul. 8, 2005.
International PCT Search Report PCT/US03/17167, 8 pages, dated Sep. 16, 2003.
International PCT Search Report PCT/US03/17203, 8 pages, dated Sep. 16, 2003.
International PCT Search Report PCT/US2004/037753, 6 pages, dated Apr. 19, 2005.
“Proven reliability for quality bone marrow samples”, Special Procedures, Cardinal Health, 6 pages, 2003.
Astrom, K. Gunnar O., “CT-guided Transsternal Core Biopsy of Anterior Mediastinal Masses,” Radiology 1996; 199:564-567, May 1996.
Astrom, K.G., “Automatic Biopsy Instruments Used Through a Coaxial Bone Biopsy System with an Eccentric Drill Tip,” Acta Radiologica, 1995; 36:237-242, May 1995.
Bio.Access.com, Single Use Small Bone Power Tool-How It Works, 1 pg, Jun. 9, 2008.
Buckley et al., CT-guided bone biopsy: Initial experience with commercially available hand held Black and Decker drill, European Journal of Radiology 61, pp. 176-180, 2007.
Cummins, Richard O., et al., “ACLS—Principles and Practice”, ACLS—The Reference Textbook, American Heart Association, pp. 214-218, 2003.
F.A.S.T 1 Intraosseous Infusion System with Depth-Control Mechanism Brochure, 6 pages, 2000.
Gunal et al., Compartment Syndrome After Intraosseous Infusion: An Experimental Study in Dogs, Journal of Pediatric Surgery, vol. 31, No. 11, pp. 1491-1493, Nov. 1996.
Hakan et al., CT-guided Bone Biopsy Performed by Means of Coaxial Biopsy System with an Eccentric Drill, Radiology, pp. 549-552, Aug. 1993.
Liakat A. Parapia, Trepanning or trephines: a history of bone marrow biopsy, British Journal of Haematoloay, pp. 14-19, 2007.
Michael Trotty, “Technology (A Special Report)—The Wall Street Journal 2008 Technology Innovation Awards—This years winners include: an IV alternative, a better way to make solar panels, a cheap, fuel efficient car and a better way to see in the dark”, The Wall Street Journal, Factiva, 5 pages, 2008.
Pediatric Emergency, Intraosseous Infusion for Administration of Fluids and Drugs, www.cookgroup.com, 1 pg., 2000.
Pediatrics, Official Journal of the American Academy of Pediatrics, Pediatrics, 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care of Pediatric and Neonatal Patients: Pediatric Advanced Life Support, Downloaded from www.pediatrics.org, Feb. 21, 2007.
Richard O. Cummings et al., “ACLS—Principles and Practice”, ACLS—The Reference Textbook, American Heart Association, pp. 214-218, 2003.
Riley et al., “A Pathologists Perspective on Bone Marrow Aspiration Biopsy: I. Performing a Bone Marrow Examination,” Journal of Clinical Laboratory Analysis 18, pp. 70-90, 2004.
Vidacare Corporation Comments to Intraosseous Vascular Access Position Paper, Infusion Nurses Society, 6 pages, May 4, 2009.
International Preliminary Report on Patent ability in International Application No. PCT/US2005/002484 dated Aug. 3, 2006.
International Preliminary Report on Patentability for international application PCT/US2006/025201, dated Feb. 7, 2008.
International Preliminary Report on Patentability for international application PCT/US2007/072202, dated Jan. 15, 2009.
International Preliminary Report on Patentability for international application PCT/US2007/078204, dated Apr. 2, 2009.
International Preliminary Report on Patentability for international application PCT/US2007/078205, dated Mar. 26, 2009.
International Preliminary Report on Patentability for international application PCT/US2007/078207, dated Mar. 26, 2009.
International Preliminary Report on Patentability for international application PCT/US2008/052943, dated Oct. 15, 2009.
International Preliminary Report on Patentability in International Application No. PCT/US/2007/072209, dated May 14, 2009.
International Preliminary Report on Patentability in International Application No. PCT/US/2008/050346, dated Jul. 23, 2009.
International Preliminary Reporton Patentability in International Application No. PCT/US2007/072217 dated Feb. 12, 2009.
International Preliminary Report on Patentability in International Application No. PCT/US2007/078203, dated Mar. 26, 2009.
International Search Report and Written Opinion for international application PCT/US2007/078203, dated May 13, 2008.
International Search Report and Written Opinion for international application PCT/US2007/078204, dated May 15, 2008.
International Search Report and Written Opinion for international application PCT/US2007/078205, dated Sep. 11, 2007.
International Search Report and Written Opinion for international application PCT/US2007/078207, dated Apr. 7, 2008.
International Search Report and Written Opinion for international application PCT/US2008/0500346, dated May 22, 2008.
International Search Report and Written Opinion for international application PCT/US2008/050346 , dated May 22, 2008.
International Search Report and Written Opinion for International Patent Application No. PCT/US2007/072202, dated Mar. 25, 2008.
International Search Report and Written Opinion issued in PCT Application No. PCT/US2007/072209 dated Apr. 25, 2008.
International Search Report and Written Opinion issued in PCT Application No. PCT/US2007/072217 dated Mar. 31, 2008.
International Search Report and Written Opinion issued in PCT/US2014/028594, dated Jul. 28, 2014.
International Search Report and Written Opinion, PCT/US08/52943 8 pages, dated Sep. 26, 2008.
International Search Report for international application PCT/US2007/072209, dated Apr. 25, 2008.
Interview Summary dated Jul. 13, 2009 and Response to Interview Summary and Amendment filed Aug. 12, 2009, U.S. Appl. No. 11/190,331, 17 pages.
Interview Summary for U.S. Appl. No. 11/190,331, dated Jul. 13, 2009.
Japanese Office Action with English Transition; Application No. 2004-508670; PCT/US03/17203; pp. 7, dated Jan. 20, 2011.
Japanese Office Action, Application No. 2004-508669, (with English summary), (9 pages), dated Aug. 3, 2009.
Japanese Office Action, Application No. 2004-508670, (with English summary), (13 pages), dated Apr. 21, 2009.
Non-Final Office Action dated Apr. 1, 2009 and Response to Office Action filed Jul. 1, 2009, U.S. Appl. No. 10/449,503, 19 pages.
Non-Final Office Action dated Mar. 23, 2009 and Response to Office Action filed Jun. 22, 2009, U.S. Appl. No. 11/190,331, 61 pages.
Non-Final Office Action dated May 29, 2009 and Response to Office Action filed Aug. 12, 2009, U.S. Appl. No. 10/449,476, 20 pages.
Non-Final Office Action, U.S. Appl. No. 10/449,476, 6 pages, dated May 29, 2009.
Non-Final Office Action, U.S. Appl. No. 10/449,476, 8 pages, dated Oct. 29, 2008.
Non-Final Office Action, U.S. Appl. No. 10/987,051, 9 pages, dated Nov. 10, 2009.
Non-Final Office Action, U.S. Appl. No. 11/042,912, 8 pages, dated Jul. 23, 2009.
Non-Final Office Action, U.S. Appl. No. 12/259,745,11 pages, dated Jul. 17, 2009.
Notice of Allowance dated Jun. 22, 2012 in U.S. Appl. No. 11/042,912.
Notice of Allowance dated Mar. 27, 2013 in U.S. Appl. No. 11/042,912.
Notice of Allowance dated Oct. 5, 2012 in U.S. Appl. No. 11/042,912.
Notice of Allowance in U.S. Appl. No. 11/042,912, dated Sep. 24, 2013.
Notice of Allowance in U.S. Appl. No. 11/253,467, dated Jun. 24, 2014.
Notice of Allowance in U.S. Appl. No. 11/380,340 dated Aug. 22, 2014.
Notice of Allowance in U.S. Appl. No. 11/619,390 dated Jul. 3, 2014.
Notice of Allowance in U.S. Appl. No. 11/619,390 dated Nov. 6, 2014.
Notice of Allowance in U.S. Appl. No. 11/620,927 dated Jun. 3, 2014.
Notice of Allowance in U.S. Appl. No. 11/853,678 dated Jul. 11, 2013.
Notice of Allowance in U.S. Appl. No. 11/853,678, dated Nov. 8, 2013.
Notice of Allowance in U.S. Appl. No. 11/853,678, dated Oct. 11, 2013.
Notice of Allowance in U.S. Appl. No. 11/853,701 dated Jul. 3, 2013.
Notice of Allowance in U.S. Appl. No. 11/853,701, dated Oct. 11, 2013.
Notice of Allowance in U.S. Appl. No. 12/331,979 dated Jul. 17, 2013.
Notice of Allowance in U.S. Appl. No. 12/331,979, dated Dec. 23, 2013.
Notice of Allowance in U.S. Appl. No. 12/899,696 dated Aug. 27, 2013.
Notice of Allowance in U.S. Appl. No. 12/899,696 dated Jul. 18, 2013.
Notice of Allowance in U.S. Appl. No. 14/271,144 dated Jul. 22, 2014.
Notice of Allowance in U.S. Appl. No. 12/259,745 dated Nov. 7, 2014.
Notice of Allowance in U.S. Appl. No. 12/407,651 dated Jun. 11, 2014.
Notice of Allowance in U.S. Appl. No. 12/427,310, dated Nov. 29, 2013.
Notice of Allowance in U.S. Appl. No. 12/718,638, dated Aug. 3, 2015.
Notice of Allowance in U.S. Appl. No. 12/899,696, dated Nov. 12, 2013.
Notice of Allowance in U.S. Appl. No. 13/966,104, dated Aug. 17, 2015.
Notice of Allowance issued in U.S. Appl. No. 11/042,912, dated Mar. 27, 2013.
Notice of Allowance issued in U.S. Appl. No. 11/253,467, dated Mar. 29, 2013.
Notice of Allowance issued in U.S. Appl. No. 11/253,467, dated Mar. 4, 2014.
Notice of Allowance issued in U.S. Appl. No. 11/253,959 dated May 20, 2013.
Notice of Allowance issued in U.S. Appl. No. 11/253,959, dated Mar. 14, 2013.
Notice of Allowance issued in U.S. Appl. No. 11/853,678, dated Mar. 27, 2013.
Notice of Allowance issued in U.S. Appl. No. 11/853,701, dated Mar. 14, 2013.
Notice of Allowance issued in U.S. Appl. No. 12/427,310, dated Jun. 5, 2013.
Notice of Allowance issued in U.S. Appl. No. 12/554,664 dated Jul. 20, 2012.
Notice of Allowance issued in U.S. Appl. No. 12/554,708 dated Jul. 11, 2012.
Notice of Allowance issued in U.S. Appl. No. 12/718,606, dated Mar. 6, 2013.
Notice of Allowance issued in U.S. Appl. No. 12/718,606, dated Oct. 11, 2012.
Notification of First Chinese Office Action, Application No. 201410112780.9, dated May 27, 2015.
Notification of the First Chinese Office Action, Application No. 200580003261.8, 3 pages, dated Mar. 21, 2008.
Office Action Action for for Chinese application 200380000182.5 (English translation) dated Jun. 27, 2013.
Office Action for Canadian application 2,612,483, dated Dec. 27, 2013.
Office Action for Chinese application 201210169546.0 with English translation, dated Apr. 18, 2014.
Office Action for European application 03731475.4, dated Oct. 11, 2007.
Office Action for European application 05712091.7, dated Sep. 21, 2007.
Office Action for European application 07842284.7, dated May 3, 2012.
Office Action for European application 07842285.4, dated May 3, 2012.
Office Action for European application 07842286.2, dated Apr. 30, 2012.
Office Action for European application 07842288.8, dated May 3, 2012.
Office Action for European application 08021732.6, dated Oct. 2, 2013.
Office Action for European application 09155111.9-2310, dated Nov. 25, 2009.
Office Action for Japanese Application No. 2004-508670 with English Translation, dated Aug. 31, 2010.
Office Action for Taiwanese application 093134480 (English Translation), dated Feb. 11, 2011.
Office Action for U.S. Appl. No. 10/449,503, dated Apr. 1, 2009.
Office Action for U.S. Appl. No. 11/042,912, dated Mar. 19, 2010.
Office Action for U.S. Appl. No. 11/042,912, dated Nov. 28, 2008.
Office Action for U.S. Appl. No. 11/190,331, dated Mar. 23, 2009.
Office Action for U.S. Appl. No. 11/253,467, dated Apr. 28, 2011.
Office Action for U.S. Appl. No. 11/253,467, dated Jul. 22, 2010.
Office Action for U.S. Appl. No. 11/253,467, dated Oct. 29, 2010.
Office Action for U.S. Appl. No. 11/253,959, dated Aug. 5, 2010.
Office Action for U.S. Appl. No. 11/253,959, dated Mar. 30, 2011.
Office Action for U.S. Appl. No. 11/253,959, dated Oct. 18, 2010.
Office Action for U.S. Appl. No. 11/427,501, dated Aug. 7, 2008.
Office Action for U.S. Appl. No. 11/427,501, dated Oct. 21, 2009.
U.S. Appl. No. 15/255,938, filed Sep. 2, 2016.
U.S. Appl. No. 12/787,228, filed May 25, 2010.
U.S. Appl. No. 11/042,912, filed Jan. 25, 2005.
U.S. Appl. No. 10/449,476, filed May 30, 2003.
Office Action for U.S. Appl. No. 11/427,501, dated May 13, 2009.
Office Action for U.S. Appl. No. 12/905,659, dated Mar. 21, 2011.
Office Action for U.S. Appl. No. 12/905,659, dated May 13, 2011.
Office Action in Canadian Patent Application No. 2,612,433, dated Aug. 22, 2014.
Office Action in Canadian Patent Application No. 2,612,483, dated Aug. 22, 2014.
Office Action in European Application No. 03756317.8 dated Dec. 28, 2006.
Office Action in European Application No. 08158699.2 dated Nov. 4, 2008.
Office Action issued in Chinese Application No. 200910006631.3, dated Mar. 22, 2011.
Office Action issued in Chinese Patent Application No. 201010144512.7, dated Feb. 23, 2011.
Office Action issued in Chinese Patent Application No. 201010144520.1, dated Jan. 27, 2011.
Office Action issued in European Application No. 09155111.9 dated Nov. 25, 2009.
Office Communication for European application 09150973.7-1269, dated Jan. 19, 2011.
Office Communication for European Patent Application No. 07842288.8, dated Mar. 12, 2015.
Office Communication in European Application No. 08021732.6, dated Jun. 20, 2013.
Office Communication in European Application No. 10153350.3, dated Jun. 14, 2011.
Office Communication issued in Chinese Patent Application No. 200910138130.0, dated Oct. 10, 2011.
Office Communication issued in European Patent Application No. 09150973.7, dated Dec. 22, 2011.
Office Communication issued in Taiwanese Patent Application No. 093134480, dated Jan. 15, 2011.
PCT Invitation to pay additional fees for international application PCT/US2006/025201, dated Oct. 26, 2006.
PCT Invitation to Pay Additional Fees in International Application No. PCT/US2007/072209 dated Dec. 3, 2007.
Request for Continued Examination and Amendment for U.S. Appl. No. 11/731,568, filed Sep. 17, 2009.
Request for Continued Examination and Amendment, U.S. Appl. No. 11/064,156, 22 pages, dated Nov. 19, 2009.
Response to Extended European Search Report in European Application No. 10153350.3, filed Jun. 30, 2010.
Response to Non-Final Office Action, U.S. Appl. No. 11/042,912, (11 pgs.), dated Oct. 23, 2009.
Response to Office Action for European application 07842284.7. Filed Nov. 10, 2012.
Response to Office Action for European application 07842285.4. Filed Nov. 13, 2012.
Response to Office Action for European application 07842286.2. Filed Nov. 8, 2012.
Response to Office Action for European application 07842288.8. Filed Nov. 9, 2012.
Response to Office Action for European application 10153350.3. Filed Mar. 17, 2011.
Response to Office Action for U.S. Appl. No. 10/449,476, filed Aug. 12, 2009.
Response to Office Action for U.S. Appl. No. 10/449,503, filed Jul. 1, 2009.
Response to Office Action for U.S. Appl. No. 11/427,501, filed Jul. 1, 2009.
Response to Office Communication in European Application No. 10153350.3, filed Feb. 9, 2012.
Response to Official Letter for European application 07842284.7. Filed Oct. 14, 2011.
Response to Official Letter for European application 07842285.4. Filed Oct. 14, 2011.
Response to Official Letter for European application 07842286.2. Filed Oct. 14, 2011.
Response to Official Letter for European application 07842288.8. Filed Oct. 14, 2011.
Search Report and Written Opinion in International Application No. PCT/US2006/025201 dated Jan. 29, 2007.
Search Report and Written Opinion in International Application No. PCT/US2007/072217 dated Mar. 12, 2007.
Search Report in European Application No. 08158699.2 dated Aug. 2008.
State Intellectual Property Office of the People's Republic of China, Notification of the Second Office Action for Chinese Application No. 200880000182.5, dated Mar. 12, 2012.
State Intellectual Property Office of the People's Republic of China, Notification of the Third Office Action for Chinese Application No. 200680000182.5, dated Dec. 13, 2012.
State Intellectual Property Office of the People's Republic of China, Reexamination Decision for Chinese Application No. 200880000182.5, dated Nov. 20, 2013.
Taiwan Office Action, Application No. 94102179 (with English translation); 12 pages, dated May 13, 2010.
Related Publications (1)
Number Date Country
20200093513 A1 Mar 2020 US
Provisional Applications (3)
Number Date Country
60539171 Jan 2004 US
60547868 Feb 2004 US
60384756 May 2002 US
Divisions (1)
Number Date Country
Parent 11042912 Jan 2005 US
Child 12787228 US
Continuations (2)
Number Date Country
Parent 15255938 Sep 2016 US
Child 16696911 US
Parent 12787228 May 2010 US
Child 15255938 US
Continuation in Parts (1)
Number Date Country
Parent 10449476 May 2003 US
Child 11042912 US